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People with spinal cord injury (SCI) are at risk of pressure ulcer development due to 
impaired mobility, sensation or changes in tissue properties.  Increased skin temperature 
is one of the least explored risk factors for pressure ulcers.  Since people with SCI also 
encounter thermoregulation deficits, investigation of the effectiveness of local skin 
cooling in this population is particularly important.  Three groups of subjects were 
recruited: 1) 14 subjects with SCI at T6 and above, 2) 8 subjects with SCI below T6, and 
3) 14 healthy controls.  Reactive hyperemic response was the main study outcome and 
was measured after three different combinations of stimuli: 1) pressure only, 2) pressure 
with fast cooling (-4°C/min) and 3) pressure with slow cooling (-0.33°C/min).  Spectral 
density of the skin blood flow (SBF) was used to investigate the underlying 
microcirculatory control mechanisms.  Five of the subjects did not have reactive 
hyperemia in all test sessions and were excluded from statistical analysis.  In the control 
group, the normalized peak SBF and perfusion area were close to significantly greater in 
pressure only as compared to fast cooling (p=0.023 and p=0.023, respectively) and slow 
cooling (p=0.033 and p=0.016, respectively).  Although this phenomenon was not 
significant when analyzing subjects with SCI alone, significant changes were observed in 
the signal attributed to the metabolic control mechanism and were observed in this 
population with pressure only (p=0.019) and pressure with slow cooling (p=0.041).  
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Yi-Ting Tzen, Ph.D. 
University of Pittsburgh, 2010
 
 v 
Since the reactive hyperemic response is mediated by different control mechanisms, the 
less obvious changes in reactive hyperemia in people with SCI may be due to alterations 
in microcirculation after injury.  Results from this study suggest that local skin cooling is 
beneficial to ischemic tissue by decreasing the metabolic demand, and this is generally 
consistent with previous animal studies and our pilot study.  Findings from this study also 
suggest that investigating time domain parameters and time-dependent spectral analysis 
of the SBF signal is helpful in understanding circulatory control in people with different 
levels of neurological deficits.  This study contributes toward justification for the 
development of support surfaces with microclimate controls to enhance tissue integrity. 
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 1 
1.0  INTRODUCTION 
People with SCI are susceptible to pressure ulcer development at weight bearing areas due to 
impaired mobility, sensation or changes in tissue properties.  Increased skin temperature is one of 
the least explored risk factors for pressure ulcers.  Previous studies found that when the skin was 
in close contact with support surfaces for a prolonged period of time, the skin temperature 
increased (Cochran, 1985; Fisher, Szymke, Aptem, & Kosiak, 1978; S. F. C. Stewart, Palmieri, 
& Cochran, 1980).  Findings from previous animal studies suggested that local cooling provided 
a protective effect of the skin during prolonged pressure (Iaizzo, et al., 1995; Kokate, et al., 
1995).  However, there was limited information on the cooling effect for people in high-risk 
populations.  In addition, there was no rationale for selecting the most effective cooling rate.  
Human thermoregulation is mediated through both central and local control mechanisms, and 
people with SCI may encounter impairments in thermoregulation due to central and/or the local 
control deficits.  So far, there is limited information on the tissue response to local cooling in the 
SCI population.  Reactive hyperemia is a non-invasive measurement widely used in examining 
tissue response to ischemia.  For this study, reactive hyperemia is used to provide information on 
the various circulatory control mechanisms when the skin is stimulated with temperature and 
pressure changes and for people with different levels of neurological deficit and those without 
SCI. 
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1.1 OBJECTIVES AND SPECIFIC AIMS 
The objective of this study was to investigate the effectiveness of local cooling on enhancing 
weight-bearing tissue tolerance on at-risk human skin. The three specific aims are: 1) to 
investigate the SBF response to local cooling at two different cooling rates in weight-bearing 
sacral tissues, 2) to investigate the difference in SBF response to local stimuli (pressure and 
cooling) on people with different degrees of neurological impairment, and 3) to investigate the 
underlying vascular control mechanisms to local stimuli on people with different degrees of 
neurological impairments.?
1.1.1 Hypothesis 1 and its rationale 
Previous animal and human studies showed that local skin cooling had a protective effect on 
ischemic tissue (Iaizzo, et al., 1995; Kokate, et al., 1995; Tzen, Brienza, Karg, & Loughlin, 
2010), possibly by decreasing the tissue metabolic rate during ischemia (Rowell, 1974).  A study 
on human vascular response during local skin cooling found that the decreased SBF with local 
cooling application was a combined result of vasodilation and vasoconstriction controlled by 
different mechanisms (Yamazaki, et al., 2006).  They also found that the initial vasodilation 
response is significantly more obvious with fast cooling than with slow cooling.  Given that the 
tissue metabolic rate depends on the tissue temperature, with less vasoconstriction response with 
fast cooling of the skin, less severe tissue ischemia was expected with fast cooling as compared 
to slow cooling. 
Reactive hyperemia has been widely used to investigate the tissue viability non-
invasively, and parameters such as normalized peak SBF and perfusion area each represent the 
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severity of tissue ischemia and metabolic repayment, respectively (Hagisawa, Ferguson-Pell, 
Cardi, & Miller, 1994).  Therefore, this physiological response was selected as an outcome 
measurement of this study by inducing this response with tissue ischemia at 60 mmHg for 20 
minutes.  Local skin cooling (both fast and slow) was applied during the 20 minutes, and was 
removed at the end of the 20 minutes.  The reactive hyperemic response was measured 
immediately after the release of 60 mmHg of pressure for 10 minutes for comparison among 
three test sessions.  A detailed diagram of the pressure and temperature applications is in section 
3.3.2. 
Based on the specific aim 1 and previously described rationale, I hypothesize that: 
1) In people with and without SCI, after cessation of 20 minutes of 60 mmHg pressure, 
a) the skin without local cooling will have a greater normalized peak SBF as 
compared to the skin with fast cooling and skin with slow cooling. 
b) the skin with slow cooling will have a greater normalized peak SBF as 
compared to the skin with fast cooling. 
c) the skin without local cooling will have a greater perfusion area as compared 
to the skin with fast cooling and skin with slow cooling. 
d) the skin with slow cooling will have a greater perfusion area as compared to 
the skin with fast cooling. 
1.1.2 Hypothesis 2 and its rationale 
People with SCI have decreased thermoregulation as compared to healthy controls (Sae-Sia, 
Wipke-Tevis, & Williams, 2007).  This may be caused by impaired thermoregulation through 
both central and local nervous systems (Kellogg, 2006).  People with complete injury level at T6 
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and above have impaired sensation as well as central control of the circulatory system.  Although 
people with complete injury below T6 have intact central control of circulation, the impaired 
sensation after injury may cause decreased thermoregulation as compared to people without SCI.  
Since the initial vasoconstriction upon local skin cooling requires both intact sensory and 
autonomic functions (Johnson, Yen, Zhao, & Kosiba, 2005), subjects with injury level at T6 and 
above were expected to have less initial vasoconstriction upon cooling as compared to subjects 
with injury level below T6 and healthy controls.  In addition, subjects with injury level below T6 
were expected to have less vasoconstriction as compared to healthy controls.  Therefore, cold 
induced vasodilation was expected to be greatest in subjects with injury level above T6 and least 
in healthy controls.  Based on this, a slighter reactive hyperemic response was expected in 
subjects with injury level at T6 and above during fast cooling, and decreases in normalized peak 
SBF and perfusion area from pressure only were expected to be greatest in this group as 
compared to the other two groups. 
Based on specific aim 2, we hypothesize that: 
2) After the cessation of 20 minutes of 60 mmHg pressure,  
a) the skin with local fast cooling during pressure application will have a greater 
decrease in normalized peak SBF from pressure only for people with injury 
level at T6 and above as compared to people with injury level below T6 and 
without SCI. 
b) the skin with local fast cooling during pressure application will have a greater 
decrease in normalized peak SBF from pressure only for people with injury 
level below T6 as compared to people without SCI. 
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c) the skin with local fast cooling during pressure application will have a greater 
decrease in perfusion area from pressure only for people with injury level at 
T6 and above as compared to people with injury level below T6 and without 
SCI. 
d) the skin with local fast cooling during pressure application will have a greater 
decrease in perfusion area from pressure only for people with injury level 
below T6 as compared to people without SCI. 
e) the skin with local slow cooling during pressure application will have a 
greater decrease in normalized peak SBF from pressure only for people with 
injury level at T6 and above as compared to people with injury level below T6 
and without SCI. 
f) the skin with local slow cooling during pressure application will have a 
greater decrease in normalized peak SBF from pressure only for people with 
injury level below T6 as compared to people without SCI. 
g) the skin with local slow cooling during pressure application will have a 
greater decrease in perfusion area from pressure only for people with injury 
level at T6 and above as compared to people with injury level below T6 and 
without SCI. 
h) the skin with local slow cooling during pressure application will have a 
greater decrease in perfusion area from pressure only for people with injury 
level below T6 as compared to people without SCI. 
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1.2 SIGNIFICANCE 
This study enhanced the understanding of the relationship between local cooling and weight-
bearing tissue tolerance in two aspects.  First, findings from this study reflected the physiological 
response of people at risk of pressure ulcer development.  Previous studies that investigated the 
effect of local cooling under pressure were performed either on animals (Iaizzo, et al., 1995; 
Kokate, et al., 1995) or on young healthy adult human subjects (Tzen, et al., 2010).  This study 
was the first to investigate the cooling effect on people with different levels of neurological 
deficit.  Secondly, results from this study provided information for selecting the most effective 
cooling rate on enhancing tissue tolerance.  Previous animal and human studies cooled the skin 
to target temperature as soon as pressure was applied (Iaizzo, et al., 1995; Kokate, et al., 1995; 
Tzen, et al., 2010).  However, a study that investigated two different cooling rates showed that 
fast cooling caused smaller vasoconstriction as compared to slow cooling (Yamazaki, et al., 
2006).  This study considers the rate of local cooling instead of just the target temperature alone, 
and findings from this work may assist in future design of support surfaces (e.g., seat cushions, 
mattresses) with local cooling features. 
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2.0  BACKGROUND 
2.1 PRESSURE ULCER DEFINITION AND PREVALENCE 
Pressure ulcers are “localized injury to the skin and/or underlying tissue usually over a bony 
prominence, as a result of pressure, or pressure in combination with shear and/or friction” 
(National Pressure Ulcer Advisory Panel, 2007a).  It is often found with people who have limited 
mobility or impaired sensation, such as people with spinal cord injury (Cardenas, Hoffman, 
Kirshblum, & McKinley, 2004; Haisma, et al., 2007; Paker, et al., 2006), hospitalized patients 
(Allman, 1997; Lindgren, Unosson, Fredrikson, & Ek, 2004), or the elderly population (Allman, 
1989; Amlung, Miller, & Bosley, 2001). 
Pressure ulcers occur in both acute and long-term care settings.  The prevalence of 
pressure ulcers ranges from 14-17% in acute care settings (Whittington & Briones, 2004), and 
remains high in chronic immobilized individuals.  In long-term care settings, the prevalence of 
pressure ulcers ranges from 15-30% in chronic SCI population (Gelis, et al., 2009; Raghavan, 
Raza, Ahmed, & Chamberlain, 2003).  People with SCI are at high risk of developing pressure 
ulcers mainly due to the impaired sensation and motor function after their injuries (Bogie & 
Bader, 2005).  The prevalence remains the same within 10 years of injury and increases slightly 
later on (Y. Chen, DeVivo, & Jackson, 2005).  The high prevalence in the SCI population makes 
pressure ulcers one of the most common secondary complications in this population (36%) along 
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with urinary track infection (47-49%) (Haisma, et al., 2007; McKinley, Jackson, Cardenas, & 
DeVivo, 1999).  They are also one of the most frequent causes for re-hospitalization in this 
population (17.9%) (Paker, et al., 2006), especially in people with complete injuries (Cardenas, 
et al., 2004). 
2.2 ETIOLOGY OF PRESSURE ULCERS 
To date, the etiology of pressure ulcer development is not yet fully understood nor fully explored 
(Bouten, Oomens, Colin, & Bader, 2005).  However, most researchers agree that prolonged 
pressure and pressure in combination with shear force are the two main etiological factors 
causing pressure ulcers (Yarkony, 1994). 
2.2.1 Prolonged pressure 
Pressure ulcers are usually located at sites that are subjected to prolonged pressure, especially 
areas of bony prominence, including malleolus, elbow, sacrum, greater trochanter, ischial 
tuberosity and heel (Bansal, Scott, Stewart, & Cockerell, 2005).  In early animal studies, 
researchers examined the effect of pressure by inducing pressure ulcers on the animals with 
different magnitudes and durations of pressure.  For example, Kosiak (1961) applied seven 
different magnitudes of localized pressure at the hamstring muscles (ranging from 35-240 
mmHg) on both normal and paraplegic rats for one to four hours.  Microscopic examination 
found that there was no change to the tissue under 35 mmHg of pressure, but when pressure was 
increased to 70 mmHg, about 10% of the muscle fiber damage was noted within two hours of 
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pressure application in both normal and paraplegic rats.  This suggests that the higher the amount 
of pressure applied to the skin, the shorter the time required to induce the tissue breakdown.?
With the enhancements in technology, later studies investigated the effect of prolonged 
pressure on at risk populations with the use of pressure mapping systems to measure the interface 
pressure and functional magnetic resonance imaging (MRI) to measure the underlying tissue 
deformation.  A study by Brienza et al. (2001) investigated the interface pressure in a group of 
at-risk elderly wheelchair users.  They found that both the mean peak pressure and the average of 
the highest four pressures were significantly higher in the people that developed pressure ulcers.  
This indicated that a higher interface pressure is related to the higher incidence of ulceration in 
the at-risk population.  To understand the effect of pressure on loading within the tissue, later 
studies from Linder-Ganz et al., quantified the compressive stress and strain of the muscle and 
fat tissues at the buttock area with the use of MRI and finite element approach (Linder-Ganz & 
Gefen, 2007; Linder-Ganz, Shabshin, Itzchak, & Gefen, 2007).  They built the finite element 
models of the buttock by using MRI with and without weight-bearing sitting in healthy 
participants.  They found that the tissue strain and stress were higher in the muscle tissue than the 
skin (Linder-Ganz, et al., 2007).  In the same paper, they further compared the internal tissue 
loads between at risk population and healthy controls and found that people at risk of pressure 
ulcer development had higher strain and stress in the muscle.  Findings from these noninvasive 
measurements all suggest that loading of the soft tissue is the main etiologic factor of pressure 
ulcer formation. 
Prolonged pressure is believed to cause ulceration through three different pathways: 
tissue ischemia, ischemic-reperfusion injury, and cell deformation (Bouten, et al., 2005). 
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2.2.1.1 Tissue ischemia 
Previous studies found the relationship between tissue ischemia and pressure ulcer 
development by inducing the tissue damage and comparing the results with changes in SBF 
before and during pressure application.  Salcido et al. (1995) applied 19 kPa (145 mmHg) of 
pressure on rats for 5 consecutive days (6 hours daily).  They found that the SBF decreased from 
a baseline value to biological zero (no flow as measured by the laser Doppler flowmeter) during 
the pressure application phase.  After the five days of pressure application, 90% of the animals 
developed pressure ulcers.  This indicated that tissue ischemia is one of the main pathways of 
ulceration.  Two studies suggested that decreased tissue oxygenation caused by tissue ischemia 
might be the underlying mechanism of tissue damage (Bader, 1990; Newson & Rolfe, 1982).  
Newson and Rolfe (1982) increased the pressure gradually until the blood flow was occluded (up 
to 40-50 kPa), and they found that the skin surface oxygen decreased with the increase of 
pressure.  Bader (1990) measured the skin oxygen level during repetitive loading on human 
subjects, and he found that the skin oxygen levels decreased during the loading periods and 
increased when the loads were removed.  A later study by Knight et al. (2001) investigated the 
oxygen level and the sweat metabolites at the sacral area of 14 human subjects during 5.3-16 kPa 
of pressure, and they report that when the tissue oxygen level is reduced to 60% below the 
baseline value, there is a significant inverse relationship between the percent reduction of oxygen 
level and sweat metabolites (i.e., lactate, urea).  This indicates that tissue oxygen is a critical 
factor of tissue metabolism and this may explain the pathway of ulceration by tissue ischemia. 
2.2.1.2 Ischemic-reperfusion injury 
Another explanation of skin breakdown is the ischemic-reperfusion injury.  A review 
article summarized that in many instances tissue damage did not occur during the hypoxia; 
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instead, it happened after tissue ischemia was relieved (McCord, 1985).  This type of injury was 
identified in different organs, including heart, brain, kidney and liver (McCord, 1985).  Pretto 
defined that ischemia-reperfusion was caused by blood reperfusion to the previously ischemic 
tissue (Pretto, 1991).  The main pathway of this type of injury is the oxidative stress caused by 
the release of reactive oxygen and nitrogen species, e.g., free radicals (Taylor & James, 2005).  
Cells have antioxidant mechanisms that maintain the balance and function of the cell.  However, 
when the release of free radicals upon reperfusion exceeds the cell’s “free radical scavenging” 
capacity, tissue damage occurs (Pretto, 1991).   
Researchers suspected that pressure ulcers might be caused by skin reperfusion as well, 
and they applied different reperfusion cycles on mice and compared the histological data 
afterwards (Peirce, Skalak, & Rodeheaver, 2000; Tsuji, Ichioka, Sekiya, & Nakatsuka, 2005).  
Peirce et al. (2000) investigated the effect of reperfusion by applying eight combinations of 
tissue ischemia and reperfusion (I/R) cycles on rats by compressing the dorsal skin at 50 mmHg.  
They measured the SBF, transcutaneous oxygen tension, and full-thickness biopsies 11.5 hours 
after the relief of the last compression cycle.  They found that with the same durations of tissue 
ischemia, increased number of I/R cycles significantly increased the necrotic area, and decreased 
the SBF and oxygen tension 11.5 hours after the last compression cycle.  They also discovered 
that with the same total amount of tissue ischemia (i.e. duration of ischemia per cycle times I/R 
cycles), the greater the number of I/R cycles, the greater the necrotic area.  The group of rats 
with only one I/R cycle had the least damage and decreased SBF as compared to sites with more 
I/R cycles.  This indicated that repeated ischemia-reperfusion were more harmful than prolonged 
ischemia alone (Peirce, et al., 2000).  Tsuji et al. (2005) investigated the microcirculatory injury 
by using similar pressure application method.  They divided mice into two groups.  Each group 
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of mice had dorsal skin compression for 8 hours in total; one group had four cycles of 
compression and release (i.e. two hours of compression and one hour of reperfusion per cycle), 
and the other group had eight hours of continuous compression.  Functional capillary density 
(FCD: total length of capillaries with red blood cell flow) was measured before (FCDpre) and 35 
hours after (FCDpost) the compression and release cycles, and the ratio of microcirculatory injury 
([1-(FCDpost/FCDpre)]*100%) was the outcome.  They found that the group with four cycles of 
reperfusion had a significantly greater ratio as compared to continuous compression only.  
Findings of this study suggest that repetitive ischemia-reperfusion damages the microcirculation 
more than prolonged pressure alone, and this might contribute to the formation of pressure 
ulcers.   
2.2.1.3 Cell deformation 
Tissue damage also may be caused by compression-induced cell deformation.  Several 
studies have investigated this effect by applying different amount of compressive strains on 
individual cells (Bouten, Knight, Lee, & Bader, 2001; Breuls, Bouten, Oomens, Bader, & 
Baaijens, 2003).  Bouten et al. (2001) applied compressive strains of 0, 10, 20, 30, and 40% on 
mouse skeletal myoblasts that were seeded within agarose constructs, and 20% of compressive 
strain corresponding to 4.3 kPa of compressive stress.  They measured the cell deformation by 
comparing the strained vs. unstrained diameters of the cell with a laser scanning microscope and 
assessed the cell damage by counting the percentage of membrane disruption or fragmentation to 
total cell number.  They found that all myoblasts and 90% of myotubes deformed with 20% of 
compressive strain, while all myoblasts and myotubes deformed with 40% of compressive strain.  
They also discovered that with 20% of compressive strain, the percentage of cell damage was 
significantly higher than the unstrained group with cell compression for as short as one hour.  
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The percentage of cell damage increased significantly with longer period of cell compression.  
Breuls et al. (2003) used a similar pressure application protocol on skeletal muscle myotubes 
embedded in gel constructs, and measured the percentage of cell damage between three different 
compressive strains: 0, 30, and 50% (30-50% corresponded to the straining levels of muscle 
tissue near bony prominences as measured with animal MRI).  They found 13.6% of cell death 
occurred immediately after 50% strain application; and four hours after strain relief, the 
percentage of cell damage was significantly greater in 50% strain than in 30% and 0% 
respectively.  This suggested that a clinically relevant amount of compression alone could induce 
tissue damage, and greater compression caused more cell injury.  A later study examined tissue 
deformation on a rat model with MRI (Stekelenburg, Oomens, Strijkers, Nicolay, & Bader, 
2006).  They applied 150 kPa of indentation on the tibialis anterior muscle on rats, and the 
pressure simulated the indentation of muscle tissue at bony prominences.  T2-weighted 
(transverse relaxation time) MR images were taken during pressure application and up to 20 
hours after pressure removal, and histology of the tissue was examined at 1, 4, and 20 hours after 
pressure removal.  They found that the signal intensity of MR images increased immediately 
upon pressure relief, and histological data showed large tissue necrosis at one and four hours 
after pressure release.  Since increased T2 has been widely recognized as a measurement for 
tissue damage, results from this study indicated that the tissue damage occurred right after 
pressure relief, and histological data supports this finding. 
2.2.2 Pressure in combination with shear force 
Shear force in combination with pressure is another etiological factor noted for causing pressure 
ulcers.  Reuler and Cooney (1981) suggested that shear force could be caused easily by lying in a 
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semi-recumbent position in the bed.  Shear is “the force per unit area exerted parallel to the plane 
of interest” (National Pressure Ulcer Advisory Panel, 2007b), and shear force alone does not 
induce skin breakdown (Bennett, Kavner, Lee, & Trainor, 1979). 
An early study from Dinsdale (1974) investigated the effect of frictional force in 
combination with pressure on ulceration.  Frictional force is “the resistance to motion in a 
parallel direction relative to the common boundary of two surfaces” (National Pressure Ulcer 
Advisory Panel, 2007b) and can be categorized as a type of shear force generated at the skin and 
superficial fascia (Wang & Sanders, 2005).  Dinsdale’s study contained two parts; the first part 
of the study examined the tissue lesion after applying different amounts of prolonged pressure 
(ranging from 160 to 1100 mmHg) for three hours with and without frictional force, and the 
second part of the study investigated the tissue damage after applying 159 mmHg of pressure for 
three 1.5 hour periods on pigs’ posterier superior iliac spines with and without frictional force.  
For the first part of the study, he found that there were no tissue damage with pressure below 480 
mmHg only, and animals with pressure and friction had more tissue damage.  However, there 
were no significant differences when the pressure was greater than 500 mmHg.  In the second 
part of the study, he found that there was significantly more tissue damage with frictional force 
in all 14 animals.  Findings from this study suggested that frictional force is a risk factor of 
ulceration and lower pressure is required to induce tissue damage with the existence of frictional 
force.  Goldstein and Sanders (1998) later investigated the effect of shear force extensively on 
ulceration by inducing tissue damage with different combination of pressure and shear.  The 
study applied different combinations of pressure (ranging from 1-16 N) and shear force (ranging 
from 1-6 N) on the greater trochanters of the pigs.  The pressure in combination with shear force 
was applied on the skin for 10-minute intervals repeatedly until tissue damage was observed or 
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up to a total of 40 minutes of load.  They found that when the tissue was loaded with the same 
amount of pressure, higher shear stress caused tissue breakdown to occur earlier.  In addition, 
they found that the highest shear stress caused the most severe tissue damage. 
The most possible pathway that explains the tissue damage caused by shear force in 
combination with pressure is tissue ischemia and hypoxia.  Bennett et al. (Bennett, et al., 1979) 
hypothesized that shear force in combination with pressure occluded the blood vessels more 
easily as compared to pressure only.  They measured the SBF at the palm of four human 
participants under two conditions: 1) pressure only and 2) pressure in combination with shear 
force.  In the first condition, the pressure was increased until the blood flow was totally 
occluded.  In the second condition, the shear force was increased incremently with the least 
amount of pressure required to prevent the loading device from slipping from the skin.  They 
found that the amount of pressure required to occlude the blood flow with pressure alone was 
about 100-120 mmHg, while the amount of pressure required to occlude the blood flow with 
shear force was about 60-80 mmHg.  From their results, they suggest that 2.7 g/cm2 of shear 
force may be equivalent to 1 mmHg of pressure to occlude the SBF.  Goossens et al. (1994) 
hypothesized that shear force in combination with pressure cut off oxygen supply more easily as 
compared to pressure only.  They investigated the skin oxygen tension at the sacrum of young 
healthy human participants under different combinations of five levels of pressure (0, 4.6, 7.7, 
10.8 and 13.9 kPa) and two levels of shear stress (0 and 3.1 kPa).  They found that the cut-off 
pressure without shear force was 11.6 kPa, and the cut-off pressure with shear force (3.1 kPa) 
was 8.7 kPa. 
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2.3 RISK FACTORS OF PRESSURE ULCERS 
In addition to pressure and shear force, several other risk factors contribute to pressure ulcer 
development.  A conceptual scheme from Braden and Bergstrom (2000) suggested that the risk 
factors causing pressure ulcers could be divided into two categories: 1) the amount and duration 
of pressure exposure and 2) the tissue tolerance toward pressure.  Given that pressure is the main 
cause of pressure ulcers, factors that increase the amount and duration of pressure exposure 
elevate the risk of pressure ulcer formation.  Lack of sensation, decreased mobility and activity 
all affect the amount and duration of pressure exposure.  The tissue tolerance toward pressure, by 
definition, is the tissue’s ability to withstand the pressure without developing ulcers (Bergstrom, 
2005).  Several intrinsic and extrinsic factors affect tissue tolerance to pressure.  The main 
intrinsic factor is changes in tissue properties due to aging or neurological deficits and the main 
extrinsic factor is increased skin temperature. 
People with SCI are at extremely high risk of developing pressure ulcers.  Spinal cord 
injury can cause different degrees of damage to the motor, sensory and autonomic functions.  
Several factors increase the risk of pressure ulcer development after SCI, including impaired 
sensation, decreased activity and immobility, changes in tissue condition and autonomic 
dysreflexia after injury (Bogie & Bader, 2005; Byrne & Salzberg, 1996).  All these deficits could 
be grouped under the two categories of the conceptual scheme described above (Braden & 
Bergstrom, 2000), and will be explained in each of the following subsections. 
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2.3.1 Impaired sensation 
Sensory perception has been used in risk assessment scales for years to predict the 
development of pressure ulcers (Braden & Bergstrom, 1988).  Spinal cord injury causes sensory 
paralysis below injury level, and this may result in lack of detection of the uncomfortable area 
exposed to prolonged pressure (Bergstrom, 2005).  Studies on SCI related risk factors in pressure 
ulcer development suggested that impaired sensation is one of the leading causes of pressure 
ulcers in this population.  Bryne & Salzberg found that completeness of injury is a major risk 
factor in this population (Byrne & Salzberg, 1996).  By definition, complete injury (American 
Spinal Injury Association (ASIA) Grade A) means no sensation or motor function at the sacral 
segments (S4-S5) (American Spinal Injury Association, 2006).  Researchers found that people 
with complete injury had higher incidence of pressure ulcer development from one to 20 years 
post-injury (McKinley, et al., 1999), and a vast majority of veterans with SCI that developed 
pressure ulcers had complete injury (69%) (Garber & Rintala, 2003). 
2.3.2 Decreased mobility and activity 
Decreased level of activity and mobility are associated with ulceration in people with SCI 
(Byrne & Salzberg, 1996) and hospitalized patients (Lindgren, et al., 2004).  Previous studies 
found that reduced spontaneous movements (Exton-smith & Sherwin, 1961) and attenuated 
movement frequency and magnitude (Nicholson, Leeman, Dobbs, Denham, & Dobbs, 1988) 
during sleeping increased the risk of ulcer development.  In addition, people who require 
assistance with their activities of daily living tend to have more pressure ulcers than those who 
did not (Berlowitz & Wilking, 1989).  In people with SCI, immobility and decreased activity 
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levels result from motor paralysis below injury level.  This leads to prolonged loading of the skin 
during sitting and lying.  Researchers found that level of mobility/activity is a risk factor in 
people with both acute (Salzberg, Byrne, Kabir, van Niewerburgh, & Cayten, 1999) and chronic 
SCI (Niazi, Salzberg, Byrne, & Viehbeck, 1997; Salzberg, et al., 1996).  In addition, the higher 
incidence of pressure ulcer development in people with complete SCI also indicates that the 
absence of motor function below the injury level plays an important role in ulceration (Garber & 
Rintala, 2003; McKinley, et al., 1999). 
2.3.3 Increased skin temperature 
Previous studies found that skin temperature increased over time when the skin is in close 
contact with support surfaces.  Researchers examined the changes in skin temperature by asking 
healthy participants to sit on different types of seat cushions and measured their skin temperature 
for a prolonged period of time (varied from 30 minutes to two hours) (Cochran, 1985; Fisher, et 
al., 1978; Seymour & Lacefield, 1985).  All three studies only reported the changes in skin 
temperature from the baseline, and they found that the skin temperature increased immediately 
when the skin is in close contact with rubber (Fisher, et al., 1978), foam and air bladder 
(Cochran, 1985; S. F. C. Stewart, et al., 1980) cushions.  On the contrary, they found that the 
skin temperature decreased immediately with the gel and water floatation cushions but increased 
thereafter in ten minutes (Cochran, 1985; Fisher, et al., 1978; S. F. C. Stewart, et al., 1980).  The 
skin temperature reached the baseline value by the end of the two hours sitting on the gel cushion 
but remained below the baseline value with the use of water floatation cushions (Cochran, 1985; 
S. F. C. Stewart, et al., 1980).  The time until skin temperature increase might be extended due to 
the high heat sink capacity of the gel and the water floatation cushions (S. F. C. Stewart, et al., 
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1980).  Similar findings were discovered in people with SCI, and the mean temperature was 
significantly higher in people with SCI regardless of the type of the cushions (Seymour & 
Lacefield, 1985).  A recent study investigating the sacral skin temperature in the lying position at 
the acute care setting also found that the skin temperature increased within the two-hour turning 
intervals in patients with acute SCI and orthopedic trauma (Sae-Sia, et al., 2007).  Findings of 
these studies all suggested that increased skin temperature is inevitable in all health care settings. 
To date, only three animal studies and one human research study investigated the relative 
effect of increased skin temperature on pressure ulcer development.  Although researchers 
generally believe that an increased tissue metabolism causes the ischemic tissue to breakdown 
faster (Rowell, 1974), the underlying mechanism of elevated skin temperature on pressure ulcer 
development is not yet fully discovered.  Findings from the animal and human studies are 
described in details in the following two subsections: section 2.3.3.1 and 2.3.3.2. 
2.3.3.1 Findings from animal studies 
Kokate et al. (1995) first investigated the relationship between the skin temperature and 
pressure ulcer development on a swine model.  They applied localized prolonged pressure of 100 
mmHg on the backs of swine for five hours under four different temperatures: 25, 35, 40, and 
45°C.  Sixteen animals were tested, and a laser Doppler perfusion monitor system was used to 
measure SBF after the operation for 28 days.  In addition, a histological evaluation was made 
after pressure removal for up to 21 days.  Histological investigation at 7 days post-operation 
showed that all tissue layers were normal under 25°C, while moderate muscle damage was found 
at sites with 35°C, and tissue necrosis at all layers were found at sites with 45°C.  The results 
were consistent with the pattern of cutaneous blood perfusion after pressure was relieved.  The 
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SBF measured at 25˚C and 35°C remained the same as the baseline value during the 28 days 
after pressure removal, while SBF measured at 45°C was absent during the whole 28 days.  
These results indicated that temperatures as high as 45°C could result in tissue damage 
immediately, whereas temperatures at 25°C could preserve the tissue viability under the same 
amount of localized pressure.  
A further study from Iaizzo et al. (1995) adopted the similar research protocol and 
performed an advanced animal study in two parts.  First they tested the same four temperatures 
with a localized pressure of 100 mmHg on the back of swine for three different amounts of time: 
two, five and ten hours.  Histological assessments were performed seven days after pressure 
removal.  They found that temperature as high as 45°C could cause tissue damage under 
localized pressure for as short as 2 hours, while sites with 25°C showed no indication of any 
tissue damage.  In addition, the severity of tissue damage increased progressively with longer 
periods of pressure applied on the skin in all temperatures above 25°C.  The second part of the 
study aimed to find the threshold temperature to prevent pressure ulcers.  They tested the effect 
of different temperatures within a smaller range (25, 27, 30, and 32°C) under 100 mmHg 
pressure for ten hours.  Histological assessment showed that the tissue damage was significantly 
lower in this range as compared to that with 35°C.  They found that the lowest temperature 
induced the least amount of damage in all layers, while the higher temperature induced tissue 
damage in more layers.  In addition, their findings suggested that deep tissue layers tend to be 
more sensitive to injury at higher temperatures.  Since they did not find any significant 
differences on tissue damage within the range of 25 to 30°C, they suggested that cooling skin to 
a temperature below 30°C might minimize the tissue damage caused by prolonged pressure. 
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Patel et al. (1999) investigated temperature effects on skin perfusion response under 
localized pressure.  They measured the skin perfusion response under three different localized 
pressures: 3.7, 18, and 73 mmHg, and two different temperatures: 28 and 36°C.  They found that 
heating the skin caused a 25% increase in perfusion under 18 mmHg of pressure, but not under 
73 mmHg pressure. The authors further investigated the skin perfusion by applying pressure 
incrementally from 3.7 to 62 mmHg under the two different temperatures.  They found that the 
skin perfusion dropped to zero when the pressure reached 55 mmHg, and that the skin perfusion 
increased from 3.7 to 18 mmHg with 36°C but not for pressure exceeding more than 18 mmHg.  
The results indicated that the application of local heating increased the skin perfusion through 
more vasodilation and reduced vascular resistance, however this did not occur when the vessels 
were mechanically occluded under higher pressure (Lachenbruch, 2005).  Based on the data 
collected by Patel et al., Lachenbrach (2005) analyzed the effect of pressure in combination with 
temperature on skin perfusion.  He found that the same amount of perfusion deficit occurred at 
both 56 mmHg with 28°C, and at 40 mmHg with 36°C.  This suggested that the presence of 
cooling preserved the tissue by reducing 29% of the pressure applied on the skin. 
Findings from all three previous animal studies suggested that local skin cooling provided 
a protective effect on ischemic tissue.  Temperature as low as 25°C is beneficial to the ischemic 
tissue on animals, however the underlying protective mechanism with local skin cooling was not 
clear. 
2.3.3.2 Findings from human study 
Our research team first investigated the effect of temperature on clinically relevant 
pressure on human subjects (Tzen, et al., 2010).  Ten young healthy adults aging from 18 to 40 
years old were recruited in this study.  The study was a repeated measures design, and each 
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subject was tested under two conditions: pressure only, and pressure with local cooling.  The 
pressure applied on the skin contained three phases: 0.4 kPa for 10 minutes, 8 kPa for 30 
minutes, and 0.4 kPa for 20 minutes.  Reactive hyperemia was the main outcome measure of the 
study, which is a normal physiological phenomenon of increased SBF after a period of tissue 
ischemia.  We found that the reactive hyperemic response was greater in non-cooling than in 
cooling, and the normalized peak SBF was significantly larger in non-cooling than in cooling.  
The normalized peak SBF represents the amount of vascular response after the release of tissue 
ischemia (Hagisawa, et al., 1994), and previous study also suggested that the more severe the 
tissue ischemia (i.e. longer period of tissue ischemia), the higher peak SBF was discovered 
(Matsubara, et al., 1998).  Given that the duration of tissue ischemia was the same in cooling and 
non-cooling, the significant decrease in normalized peak SBF indicated that local cooling 
provided a protective effect of the tissue ischemia (Tzen, et al., 2010).  We further analyzed the 
underlying mechanism using time-dependent spectral analysis.  Although not statistically 
significant, we found that the myogenic activity remained elevated throughout the hyperemic 
response with cooling, while the myogenic activity elevated initially and returned to baseline 
without cooling.  A previous study suggested that the decreased myogenic response during and 
after heating of the skin was the result of decreased smooth muscle tone (Geyer, Jan, Brienza, & 
Boninger, 2004).  Therefore, our finding implied that local cooling increased the smooth muscle 
tone and caused local vasoconstriction.  This study provided pilot results of the temperature 
effect on ischemic tissue in human subjects, however due to the small sample size, we were not 
able to distinguish the underlying mechanism of temperature on ischemic tissues. 
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2.3.3.3 Impaired thermoregulation in people with SCI 
Sae-sia et al. (2007) measured the sacral skin temperature of people with SCI at the acute 
care clinic and found that people with higher skin temperature had higher incidence of pressure 
ulcer development.  To date there is no direct linkage between thermoregulation and pressure 
ulcer development; however, given that increased temperature causes the skin to be more 
vulnerable to tissue damage under prolonged pressure, changes in thermoregulation in people 
with SCI may affect the tissue tolerance toward pressure during weight-bearing conditions. 
Both central and local control mechanisms modulate human thermoregulation through the 
peripheral circulation system (Kellogg, 2006).  The central vascular control mechanism is 
mediated via the sympathetic nervous system (Holowatz, et al., 2003; Johnson, et al., 2005; 
Kellogg, et al., 1995; Scremin & Kenney, 2004), and the local vascular control mechanism is 
mediated through different local neural and non-neural responses (Johnson, et al., 2005; Kellogg, 
2006; Minson, Berry, & Joyner, 2001; Pergola, Johnson, Kellogg, & Kosiba, 1996).  Depending 
on the level and type of injury, SCI may result in impairments in sensation and/or autonomic 
function.  Impairments in either sensory or autonomic function may affect the peripheral 
circulatory control system through the central or local control mechanisms. 
(a) Central control mechanisms 
The central control of the thermoregulation contains two pathways: active vasodilation 
during heat stress and noradrenergic vasoconstriction during cold stress (Holowatz, et al., 2003; 
Johnson, et al., 2005; Kellogg, et al., 1995; Scremin & Kenney, 2004).  Previous studies found 
that the cholinergic nerves release acetylcholine (Hokfelt, Johansson, Ljungdahl, Lundberg, & 
Schultzberg, 1980) and another cotransmitter (Kellogg, et al., 1995), possibly vasoactive 
intestinal peptide, during heating.  Acetylcholine mainly caused the sweating response, while the 
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vasoactive intestinal peptide caused the vasodilation of the cutaneous arterioles.  However, the 
interactions of the two neurotransmitters and vasodilation were not completely identified.  Later 
studies discovered that acetylcholine modulated the vasodilation response through the nitric 
oxide synthase mechanism (Shibasaki, Wilson, Cui, & Crandall, 2002), and a functional nitric 
oxide synthase played an important role in active vasodilation (Kellogg, Crandall, Chrarkoudian, 
& Johnson, 1998; Shastry, Dietz, Halliwill, Reed, & Joyner, 1998).  The sympathetic 
noradrenergic nerve releases two neurotransmitters causing active vasoconstriction of the 
cutaneous arterioles during cooling (Kellogg, 2006).  The two neurotransmitters are 
norepinephrine and neuropeptide Y (NPY), and they induce the vasoconstriction through the α1, 
α2 receptors (Flavahan, 1991; Johnson, et al., 2005) and postjunctional NPY Y1 receptors of the 
vascular smooth muscles, respectively (Stephens, Aoki, Kosiba, & Johnson, 2001; Stephens, 
Saad, Bennett, Kosiba, & Johnson, 2004).   
People with SCI level at T6 and above usually encounter impaired central control over 
the circulation system (Bogie & Bader, 2005).  This could lead to the condition of autonomic 
dysreflexia, which is an increased autonomic reflex response to various irritating stimuli (Byrne 
& Salzberg, 1996).  Petrofsky (1992) investigated the aural temperature of people with and 
without SCI.  Four people without any neurological deficits and twelve people with complete 
SCI (six with injury level between T7-T12 and another six with injury level between C6-C8) 
were recruited.  The core temperature and the sweat rate were measured with and without upper 
extremity exercise under three different environmental temperatures (30, 35, and 40°C).  He 
found that people with injury level between C6-8 had higher core temperature regardless of the 
environmental temperature and the exercise condition.  In addition, this group had the lowest 
sweating rate and the difference from control group was especially obvious with higher 
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environmental temperature.  This indicated that people with a higher level of injury have a 
limited capacity for thermoregulation, and this may be due to inability to sweat after the 
autonomic function impairment.   
(b) Local control mechanisms  
Local heating of the skin induces two local control mechanisms: the sensory reflex 
(neural), and the local nitric oxide generation (non-neural) mechanism (Minson, et al., 2001).  
Studies found that increased in SBF with local heating was mediated by sensory reflex (Minson, 
et al., 2001) and local nitric oxide production (Kellogg, Liu, Kosiba, & O'Donnell, 1999).  In 
addition, the two local control mechanisms are independent of the function of the adrenergic 
system (central control mechanism) (Pergola, Kellogg, Johnson, Kosiba, & Solomon, 1993).  
Local cooling of the skin induces two phases of vasoconstriction (Johnson, et al., 2005).  The 
initial decrease in SBF is a result of combined noradrenergic vasoconstriction and non-
neurogenic vasodilation (Johnson, 2007).  The noradrenergic vasoconstriction requires intact 
sensory and autonomic functions (Johnson, et al., 2005), while the non-neurogenic vasodilation 
depends on the cooling rate of the skin (Yamazaki, et al., 2006).  The prolonged phase of 
vasoconstriction is mediated through another non-neurogenic mechanism, and the Rho-Rho 
kinase system is partially attributed to this mechanism (Thompson, Holowatz, Flavahan, & 
Kenney, 2007). 
To date, there is limited literature that examines the local thermoregulatory response in 
people with SCI.  Price (2006) reviewed articles that investigated thermoregulation during 
exercise in people with different degrees of SCI.  As compared to people without SCI, people 
with thoracic or lumbar spinal lesions showed similar core temperature but greater heat storage 
in the lower limbs during exercise regardless of the environmental temperature.  The results 
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suggested a lower heat dissipating rate in this population, however, the underlying mechanisms 
causing this difference remain unclear. 
2.3.4 Changes in tissue property 
One common characteristic of the high-risk population is changes in tissue property.  
Researchers found that elderly people and people with SCI had several differences in tissue 
property as compared to populations not at-risk of pressure ulcer development.  A recent survey 
showed that more than 50% of the people with pressure ulcers are over 70 years old (Amlung, et 
al., 2001).  Studies found the elasticity and subcutaneous fat of the skin decrease with normal 
aging (Garcia & Thomas, 2006); and the epidermis, dermis and the vessel walls become thinner 
as compared to younger population (Witkowski & Parish, 2000). 
In people with SCI, there are several changes in tissue property that may cause the skin to 
become more vulnerable to ulceration, including disuse muscle atrophy and changes in body 
composition.  Castro et al. (1999) did biopsies at the right vastus lateralis muscle in fifteen 
people with complete SCI at three time points: 6, 11, and 24 weeks after injury.  They found that 
the average fiber cross-sectional area declined significantly (27-56%) from week 6 to week 24.  
In addition, the relative percentage of type IIa fiber decreased significantly during this period of 
time, while type IIax+IIx increased.  They suggested that the muscle atrophy recognized in all 
fiber types might be due to the loss of contractile protein within the skeletal muscles.  A review 
article from Giangreporio and McCartney (2006) identified several soft tissue composition 
changes after SCI.  The total fat mass and the percentage of fat mass in the lower limbs were 
higher in people with SCI.  However these studies didn’t show a direct linkage between changes 
of body composition and ulcer formation.  A recently study from Linder-Ganz et al. (2008) 
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investigated the sub-dermal tissue of the buttocks in people with SCI under both weight-bearing 
and non-weight-bearing conditions.  They found that the gluteal muscle thickness was generally 
thinner in people with SCI as compared to healthy controls at non-weight-bearing condition.  In 
addition, the computer model built from integrating images formed by MRI showed a 
significantly higher strain and stress in both muscle and fat tissue in people with SCI.  Since the 
test protocol was the same for all subjects, the differences in strain and stress during the weight-
bearing condition might be due to the anatomical changes in people after injury.  They used the 
same test protocol to measure the strain and stress on people with SCI while sitting on 
commercially available pressure redistribution cushions (Linder-Ganz, et al., 2008).  The peak 
gluteal stress was 3-5 times greater in people with SCI than controls, and the integrated peak 
compression stress over time was 35-50 times greater in people with SCI than controls.  Results 
of this study were consistent with their previous finding that anatomical changes after injury 
caused higher stress on the tissue during the weight-bearing situation. 
2.4 BENEFITS OF LOCAL SKIN COOLING 
Since increased skin temperature is one of the risk factors causing pressure ulcers, local skin 
cooling is believed to be a potential method to prevent ulceration.  Cooling has been used in 
various fields for tissue preservation, including organ transplants, stroke (Erecinska, Thoresen, & 
Silver, 2003; Zhao, Steinberg, & Sapolsky, 2007), bypass surgery (Q. Chen, et al., 2002; Riess, 
Camara, Kevin, An, & Stowe, 2004) and free-flap surgery (Diederich, et al., 2009).  Several 
mechanisms contribute to the protective effect of cooling including reduced metabolic demand 
 28 
during tissue ischemia, decreased ischemic-reperfusion injury and diminished inflammation 
response. 
2.4.1 Reduced metabolic demand during tissue ischemia 
Decreased temperature causes the metabolic-arresting effect (Hochachka, 1986), which is a 
protective effect of reducing tissue metabolism by cooling.  This effect has been recognized in 
different tissues, including skeletal muscles (Segal & Faulkner, 1985; Seiyama, Kosaka, Maeda, 
& Shiga, 1996), cutaneous tissue, and even heart (Q. Chen, et al., 2002; Chitwood, Sink, Hill, 
Wechsler, & Sabiston, 1979; Riess, et al., 2004)  and brain (Rosomoff & Holaday, 1954). 
Seiyama et al. (1996) examined the metabolic-arresting effect of hypothermia on isolated 
rat skeletal muscle by measuring the O2 consumption (difference of influent and effluent O2 
concentration) under different tissue temperature.  They found that with the same influent 
oxygen concentration, the muscle at higher temperature had more O2 uptake.  In addition, they 
measured the myoglobin and cytochrome oxygenation with a spectrophotometer and found that 
lower temperature increased oxygenation of myoglobin and cytochrome of the muscle cell.  
Findings from this study indicate that hypothermia decreases the metabolic rate of the skeletal 
muscle, and diminishes the respiratory rate of the mitochondria or electron flow of the cell 
respiratory chain.  Michenfelder and Milde (1991) examined the changes of metabolism and 
cerebral function with mild hypothermia.  They investigated the cerebral metabolism on adult 
dogs by measuring the ratio of two rates of oxygen consumption measured over a 10°C range.  
They cooled the brain from 37°C to 14°C, and found that the rate of oxygen consumption 
decreased about 55-60% for every 10°C of brain tissue temperature reduction.  Results from this 
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study suggested that hypothermia had a potential protective effect for the brain.  However, they 
did not report any data on brain function when the temperature decreased. 
Erecinska et al. (2003) reviewed articles that investigated hypothermia on energy 
metabolism in mammalian brain.  In addition to the oxygen metabolic rate, they reviewed 
previous studies that investigated the cerebral metabolic rate of glucose and lactate.  From eight 
previous studies that measured the cerebral metabolic rates ranging from 18 to 41°C, they found 
that both the metabolic rates of glucose and lactate were reduced when the tissue temperature is 
lower.  Calculations derived from data collected in eight previous studies suggest that the 
cerebral metabolic rate of glucose and lactate is reduced about two to four fold when the tissue 
temperature is reduced 10°C. 
2.4.2 Decreased ischemia-reperfusion injury 
The other explanation of hypothermia on tissue survival is to reduce the ischemia-
reperfusion injury, which is one of the etiological factors of pressure ulcer development.  Choi et 
al. (2005) investigated the hepatic injury after 24 hours of reperfusion in the rat liver.  Tissue 
ischemia was induced for 75 minutes under two conditions: normothermia (37°C) and mild-
hypothermia (34°C).  Histological assessment was performed 24 hours after ischemia relief to 
measure the hepatic injury.  They found that there was more than 75% of necrosis in 
normothermic condition, whereas the mild hypothermia reduced the tissue necrosis about 25 to 
50%.  In addition, after 24 hours of reperfusion, the survival rate was significantly lower in the 
normothermic group.  Diederich et al. (2009) investigated the protective effect of hypothermia 
on dissected rat rectus femoris muscles.  Tissue ischemia was induced for one hour to simulate 
the procedure of free flap transfer, and the skin temperature was controlled at three different 
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levels during tissue ischemia: local cooling at 10°C, exposing to room temperature (23°C) and 
local heating at 30°C.  They found that there is significantly less muscle necrosis following local 
cooling compared to the other two temperature conditions.  Results from both studies indicated 
that there is a protective effect of cooling that reduces ischemia-reperfusion tissue injury. 
In light of the beneficial effect of cooling on reperfusion injury described in previous 
paragraph, other studies investigated the timing of the cooling intervention during ischemia and 
reperfusion.  Mowlavi et al. (2003) investigated the muscle tissue viability and muscle edema 
under four conditions: 10°C local cooling during 1) four hours of tissue ischemia only, 2) the 
initial three hours of reperfusion, 3) four hours of tissue ischemia and the initial three hours of 
perfusion, and 4) no local cooling.  They found that the muscle viability was significantly higher 
in all three hypothermia groups as compared to no cooling.  In addition, the muscle edema was 
significantly reduced in all three hypothermia groups as compared to no cooling.  The results 
indicated local cooling intervention during early reperfusion could provide a protective effect on 
reperfusion injury.  Another study investigated the myocardial tissues with the cooling 
intervention given continuously before, during and after tissue ischemia (Kanemoto, et al., 
2009).  They found that all groups with cooling intervention significantly reduced the infarct size 
of the myocardial tissues as compared to group without cooling intervention.  In addition, they 
discovered that the tissue temperature at reperfusion is correlated with the size of infarction.  The 
results also suggested that hypothermia provided a protective effect on tissue during reperfusion. 
2.4.3 Selection of different cooling rates 
Given that local cooling might provide a protective effect on skin under localized 
pressure, there is no rationale on selecting the cooling rate.  Kellogg reviewed the physiological 
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response of the vessels during local cooling (Kellogg, 2006).  He summarized that the vascular 
response mechanisms during local cooling could be explained in two phases.  The initial 
decrease of SBF is the combined result of two mechanisms: sympathetic vasoconstriction, and a 
vasodilation that is not modulated by the nervous system.  The prolonged phase of decreased 
SBF is mediated by another non-neural vasoconstriction.  Yamazaki et al. (2006) investigated the 
initial cold induced vasodilation with two different cooling rates and found that this mechanism 
was rate dependent.  They cooled the forearm skin at two different rates: fast cooling (-4°C/min) 
and slow cooling (-.33°C/min).  To unmask the initial vasodilation response, the initial 
sympathetic vasoconstriction was blocked with bretylium tosylate (adrenergic transmitter 
blocker).  The initial vasodilation response was observed in the fast cooling but not in slow 
cooling.  To further understand the control mechanism of this initial vasodilation, nitric oxide 
synthase inhibitor was applied during the process of local cooling.  They found that nitric oxide 
synthase inhibitor did not significantly decrease the SBF during the early stage of local skin 
cooling.  The results suggest that the initial cold-induced vasodilation is rate dependent, however 
the control mechanism of this response remains unclear but does not appear to be primarily 
mediated by nitric oxide.  In addition, there was no evidence on how long the vasodilation lasted 
during the period of local cooling. 
Literature reviews from section 2.4.1 suggest that the local cell metabolic rate depends on 
surrounding tissue temperature.  Since there was a limitation of increasing SBF with heating 
when the vessels were mechanically constricted by high pressure (Patel, et al., 1999), application 
of fast cooling might cause less vasoconstriction of the skin as compared with slow cooling 
under the same amount of mechanical pressure on the skin.  Since the tissue metabolic rate 
depends on the tissue temperature, with the same tissue metabolic rate (skin cooled to the same 
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temperature with both fast and slow cooling) and more blood flow supply to the target tissue 
(fast cooling induced initial vasodilation), we might be able to preserve the tissue tolerance under 
localized pressure with fast cooling. 
2.5 INDIRECT MEASUREMENT OF TISSUE RESPONSE 
To investigate the cooling effect on human subjects, a non-invasive measurement method should 
be used to test the differences.  Previous pressure ulcer studies in the lab setting used numerous 
non-invasive measurement tools to investigate the effect of risk factors (e.g. pressure, shear, 
smoking, and changes in tissue conditions) on pressure ulcer development.  The outcome 
measures used most often in the literatures were arterial oxygen tension and reactive hyperemia.  
To measure the arterial oxygen tension, a transcutaneous oximetry (TcPO2) should be used (Jan 
& Brienza, 2006; Newson & Rolfe, 1982).  It is a reliable method to measure tissue viability by 
assessing the blood gas that is permeated to the surface of the skin (Togawa, Tamura, & Öberg, 
1997a).  Since the skin is not permeable to gas, heating the skin up to 40-45°C is required to 
obtain an accurate reading of the oxygen tension (Bongard & Bounameaux, 1993; Jan & Brienza, 
2006).  Given that a cooling intervention was provided in this study, it was not appropriate to use 
TcPO2 as an outcome measurement tool. 
2.5.1 Reactive hyperemia 
The reactive hyperemic response was selected as an outcome measurement tool for this research.  
It has been adopted in several pressure ulcer studies that tested human subjects (Hagisawa, et al., 
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1994; V. Schubert & Fagrell, 1991b; Sprigle, Linden, & Riordan, 2002), and it has also been 
used in numerous studies that investigate the micro-vascular function in people that are smokers 
(Noble, Voegeli, & Clough, 2003), the elderly population (V. Schubert & Fagrell, 1991a), and 
for people at high risk for developing cardiovascular diseases (Matsubara, et al., 1998; Ruano, et 
al., 2005; Skrha, Prazn, Haas, Kvasnicka, & Kalvodova, 2001; J. Stewart, et al., 2004). 
Reactive hyperemia is a normal physiological response that occurs after a period of tissue 
ischemia in many different organs of the human body (Levick, 2003; Wilkin, 1987), including 
but not limited to the skin, liver, heart, and brain.  A reactive hyperemic response is a sudden 
increased blood flow that appears immediately after the release of vessel occlusion. The blood 
flow rises from biological zero (blood flow during vessel occlusion) to a peak then gradually 
descends to the baseline value (blood flow before vessel occlusion).  It can be induced easily by 
blocking the SBF for as short as three minutes (Cracowski, Minson, Salvat-Melis, & Halliwill, 
2006), and it lasts about one half of the time of the tissue ischemia (Sprigle, et al., 2002). 
2.5.1.1 Physiological control mechanisms of reactive hyperemia 
Researchers to date agree that the main explanation for the occurrence of reactive 
hyperemia is to erase/correct the oxygen and nutritional debt accumulated during tissue ischemia 
(Hagisawa, et al., 1994; Levick, 2003).  However, the underlying mechanisms are not completely 
understood.  There are three main mechanisms that contribute to the hyperemic response, 
including accumulation of metabolic vasodilators, neurogenic and myogenic responses 
(Cracowski, et al., 2006).   
Two previous studies have identified several metabolic substances that contribute to 
vasodilation during the reactive hyperemic response.  These substances included prostaglandin 
and adenosine. Studies that investigated the contribution of the metabolic substances tested the 
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reactive hyperemia under the condition with and without the inhibitor or drug that blocks the 
release of these metabolic substances.  Kilbom and Wennmalm (1976) investigated the effect of 
prostaglandin (metabolic substance generated by endothelial cells) on reactive hyperemia at 
human forearms.  They measured the reactive hyperemic response with and without 
indomethacin (an inhibitor of prostaglandin), and found that the reactive hyperemic response was 
smaller with the use of indomethacin.  This indicated that prostaglandin is one of the metabolic 
substances released during reactive hyperemia.  Carlsson, Sollevi and Wennmalm (1987) 
measured the effect of adenosine on reactive hyperemia with and without theophylline 
(adenosine receptor antagonist).  Adenosine is a degradation product of adenosine triphosphate, 
which is a substance of cell metabolism.  They found that theophylline reduces 35% of the 
reactive hyperemia, indicating that adenosine plays a role in the reactive hyperemic response and 
proved that tissue metabolism contributes to the response.   
Myogenic control mechanism of blood flow is caused by the changes in transmural 
pressure of the vessel (R. Schubert & Mulvany, 1999).  This control mechanism was first 
investigated about a century ago by inducing the reactive hyperemic response on denervated dog 
femoral arteries with short period of blood flow occlusion (Bayliss, 1902).  Bayliss suggested 
that the response was independent of the central nervous system, since the animals were 
anesthetized, however, the contribution of metabolic and peripheral nervous system to reactive 
hyperemia was not completely blocked in this early study.  A recent study investigated the 
myogenic response by measuring the reactive dilation under the stimuli of changing 
hemodynamic forces, including pressure and flow (Koller & Bagi, 2002).  Reactive dilation is 
the change in the diameter of the vessel, and it is the outcome measure of the study to simulate 
the reactive hyperemia in vivo.  To eliminate other factors that might affect the reactive 
 35 
hyperemia, they performed the tests on isolated rat skeletal muscle arterioles.  They found that 
when the pressure was changed, the peak reactive dilation increased but not the duration.  They 
also found that when the pressure and flow were changed, both the peak and duration of the 
reactive dilation increased.  To distinguish the substances that contributed to the response, they 
further performed the same protocol after endothelium removal and inhibition of nitric oxide 
synthase.  They found that inhibition of NO synthase and endothelium removal significantly 
reduced the peak, this indicated that deformation of the endothelial cell releases the nitric oxide, 
therefore causing the vasodilation.  This study suggested that the stretch, deformation, pressure 
and changes in flow induced the reactive hyperemia, and this response was mediated partly by 
the release of nitric oxide.   
The reactive hyperemic response is also mediated through sensory nerves.  Larkin and 
Williams (1993) investigated the skin reactive hyperemic response by blocking the sensory 
nerves with local anesthesia.  They found that the reactive hyperemic response was significantly 
reduced with the anesthesia, however the neurotransmitter that is responsible for this response 
was not identified.  A later study investigated the neurogenic response and its interaction with the 
calcium activated potassium (BKCa) channels (Lorenzo & Minson, 2007).  BKCa channel 
regulates the vascular tone and is activated by increased concentration of Ca2+ and depolarization 
of the cell membrane (Jackson, 2000).  They found that the reactive hyperemia was significantly 
reduced with both blockers independently and in combination.  Therefore they suggested that 
both the sensory nerves and the BKCa channels mediated the reactive hyperemic response. 
2.5.1.2 Parameters of reactive hyperemia 
To quantify the hyperemic response and characterize the underlying mechanisms, several 
parameters were identified in previous studies (Hagisawa, et al., 1994; V. Schubert & Fagrell, 
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1991a; Sprigle, et al., 2002).  The most commonly used parameters of reactive hyperemia 
include baseline SBF, peak SBF, time to peak SBF, half-life of SBF and perfusion area, and each 
parameter corresponds to different mechanisms.  Figure 1 is a typical reactive hyperemia 
response collected from subject CTRL_06 in this study, baseline SBF is the SBF measured 
before tissue ischemia; peak SBF is the maximum value of SBF that occurs after the end of 
tissue ischemia; time to peak SBF is the time period between the end of tissue ischemia and the 
peak SBF; the half-life is the time period between peak SBF and the half-way of SBF descending 
from the peak SBF; and the perfusion area is the area for the reactive hyperemia curve above the 
baseline value. 
 
Figure 1. Reactive hyperemia time domain parameters. 
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Peak SBF is the most widely used parameter of the reactive hyperemia.  It represents how 
extensively the vessels react to ischemia (Hagisawa, et al., 1994); in addition, it indicates the 
severity of tissue ischemia since longer duration of tissue ischemia induces higher peak SBF 
(Matsubara, et al., 1998).  Time to peak SBF is another broadly adopted parameter.  It represents 
how fast the vessel reacts to tissue ischemia (Hagisawa, et al., 1994) and is thought to reflect the 
cutaneous vascular resistance of the measured sites (Sprigle, et al., 2002; Yvonne-Tee, Rassol, 
Halim, & Rahman, 2005).  Both the peak SBF and the time to peak SBF are highly reproducible 
measures (Yvonne-Tee, et al., 2005).  Half-life represents the gradual decrease in vasodilation 
response after the peak SBF (Hagisawa, et al., 1994) and the duration of reactive hyperemia 
(Noble, et al., 2003).  A study on smokers and non-smokers suggested that this vasodilation 
response is nitric oxide dependent since the endothelial nitric oxide synthase was inhibited with 
smoking (Noble, et al., 2003).  Perfusion area represents the metabolic repayment after the tissue 
ischemia (V. Schubert & Fagrell, 1991b).  Details and definition of each parameter are described 
in section 3.5. 
2.5.2 Laser Doppler flowmetry system 
To detect the reactive hyperemic response, the laser Doppler flowmetry (LDF) was selected. 
LDF is a method to measure SBF continuously and non-invasively (Togawa, Tamura, & Öberg, 
1997b).  The mechanism of using LDF to measure skin microcirculation is through projecting a 
laser beam to the skin, then collect the scattered light through the optical fibers (Togawa, et al., 
1997b).  It has been used in many studies on pressure ulcers risk assessment (V. Schubert & 
Fagrell, 1991b), endothelial function (Cracowski, et al., 2006), and tissue viability after free flap 
surgery (Holzle, Loeffelbein, Nolte, & Wolff, 2006).  LDF has been shown to be a reliable tool 
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for monitoring skin perfusion (Kind, et al., 1998; Yuen & Feng, 2000).  In addition, Ghazanfari 
et al. (2002) found that LDF had high test-retest reliability (r =.81, p <.01). 
2.6 SKIN BLOOD FLOW SIGNAL PROCESSING 
Skin blood flow signals obtained from the laser Doppler flowmetry contain information 
regarding the physiological response of the skin during and after tissue ischemia.  Signal 
processing of the SBF in time and frequency domains provides information on the physiological 
response after the release of tissue ischemia.  Skin blood flow signal was analyzed using two 
signal processing methods to characterize the reactive hyperemic response in both time and 
frequency domains.  An exponential curve-fitting technique was used to select the time-domain 
parameters of the reactive hyperemia, while time-frequency analysis was used to examine the 
different control mechanisms of the SBF during the reactive hyperemia. 
2.6.1 Exponential curve-fitting of the reactive hyperemia 
To identify the parameters of the reactive hyperemia for statistical analysis, the reactive 
hyperemic response has to be recognized in the first place.  Previous studies that used laser 
Doppler flowmetry to measure the SBF showed that there were oscillations of the SBF during 
baseline and reactive hyperemia (Cracowski, et al., 2006; Rossi, et al., 2007; J. Stewart, et al., 
2004).  Researchers examined the SBF in frequency domain and suggested that these very low 
frequency oscillations (ranging from 0.008-0.15Hz) represented three physiological control 
mechanisms: metabolic, neurogenic and myogenic mechanisms (Azman-Juvan, Bernjak, 
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Urbancic-Rovan, Stefanovska, & Stajer, 2007; Bracic & Stefanovska, 1998; Stefanovska, Bracic, 
& Kvernmo, 1999).  Details of each frequency band are described in section 2.6.2.  Given that 
the oscillation of SBF provided information of underlying control mechanisms, the low 
frequency of blood flow oscillation should not be filtered for the purpose of selecting the time 
domain parameters of the reactive hyperemia.?
All previous studies that used reactive hyperemia as outcome measures selected the 
parameters by visually detecting the blood flow.  However, the accuracy of each parameter might 
be questionable since there was no rationale on selecting from several blood flow points and 
visually selecting parameters is subjective and may vary from person to person (Humeau, 
Saumet, & L'Huillier, 2000).  Nevertheless, studies to date still select parameters with this 
method.  In contrast, a physical model of the post-occlusive reactive hyperemia has been 
developed by simulating the flow response with a circuit, containing voltage as the pressure, 
resistor as time-varying resistance of the capillary and current as the flow (de Mul, Morales, 
Smit, & Graaff, 2005).  Figure 2 shows a circuit that simulate the blood flow response during 
reactive hyperemia developed by de Mul and colleagues.  V0 and V1 represent the aortic pressure 
and arterial pressure, respectively.  R1, R2, R3 and R4 represent the flow resistance, and C1 and C2 
represent the compliance of the vessel (ratio of changes in blood volume to pressure).  Current 
‘I’ is the peripheral blood flow.  Based on Ohm’s Law, I=V/R, current ‘I’ in Figure 2 can be 
derived as Equation 1.  In Equation 1, p1, p2 are constants, and t is time.  This reactive hyperemia 
flow model has the characteristic of starting from zero at the beginning of reactive hyperemia 
(t=0) and reaches the resting blood flow when time approaches infinity (t∞).  Equation 1 could 
be simplified to Equation 2, which is a simple bi-exponential function of time t.  Symbol y(t) is 
the blood flow curve (function of time t), and A1, A2, B, τ1, τ2 are constants.  To objectively select 
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the time domain parameters of the reactive hyperemia, a least-squares curve fit of this bi-
exponential function (Equation 2) to the blood flow data in this study was performed (details 
described in section 3.5.1). 
 
Figure 2. Physical model of reactive hyperemia. 
V0 and V1 represent the aortic pressure and arterial pressure, respectively.  R1, R2, R3 and R4 
represent the flow resistance, and C1 and C2 represent the compliance of the vessel (ratio of 
changes in blood volume to pressure).  Current ‘I’ is the peripheral blood flow. 
Equation 1. Current ‘I’ in Figure 2 calculated based on Ohm’s Law. 
€ 
I = V0R4 (R1 + R2 + R3) + R1(R2 + R3)
1+ 1p2 − p1
(C2R3p1p2 − p2)e− p1t − (C2R3p1p2 − p1)e− p2t{ }
⎡ 
⎣ 
⎢ 
⎤ 
⎦ 
⎥  
Equation 2. Bi-exponential function of time simplified from Equation 1. 
€ 
y(t) = A1e− t /τ1 + A2e− t /τ2 + B 
2.6.2 Time-frequency analysis of the SBF signal 
In addition to the parameters of reactive hyperemia described previously, SBF signals can also 
be analyzed in the frequency domain (Bracic & Stefanovska, 1998, 1999; Stefanovska, et al., 
1999).  Five frequency bands were identified in previous studies, and each frequency band 
corresponds to a specific mechanism that controls the SBF.  They are the metabolic (0.008-0.02 
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Hz), neurogenic (0.02-0.05 Hz), myogenic (0.05-0.15 Hz), respiratory (0.15-0.4 Hz), and cardiac 
(0.4-2.0Hz) mechanisms.  An early study computed spectral analysis of the heart rate variability 
signal and identified two characteristic peaks centered around the heart beat (1 Hz) and the 
respiratory frequency (0.3 Hz) (Di Renzo, Marncia, Parati, Pedott, & Zanchetti, 1995).  Based on 
this finding, Bracic and Stefanovska (1999) examined the energy densities using wavelet 
transform between the SBF signal and the heart rate variability signal.  They found that there 
were also two characteristic peaks that centered at the two frequencies identified in the previous 
studies, and these two frequencies corresponded to the cardiac and the respiratory control 
mechanisms of the SBF.  Another characteristic peak centered around 0.1Hz was identified in the 
blood-pressure signal (Bracic & Stefanovska, 1998).  Since smooth muscle movement was 
activated through the changes of intravascular pressure and is primarily responsible for the 
blood-pressure regulation, this frequency band was identified as the myogenic response of the 
SBF (Cracowski, et al., 2006).  Kastrup et al. (Kastrup, Bülow, & Lassen, 1989) applied local 
and ganglionic nerve blockers on the skin.  They found that the peak centered about 0.025 Hz 
was diminished significantly with the nerve blockers.  This indicated that this frequency band 
represented the neurogenic control mechanism of the SBF.  Stefanovaska et al. (1999) examined 
the characteristic peak about 0.0095-0.02Hz of the spectra with and without the endothelium-
dependent vasodilators.  They found that the energy densities increased significantly with the use 
of the vasodilators.  This indicated this frequency band corresponded to the metabolic control 
mechanism of the SBF. 
Frequency analysis of signals has been used in various fields for decades.  Frequency 
description of a signal helps us learn about the source of the signal and simplifies our 
understanding of the waveform (Cohen, 1995c).  Traditional Fourier analysis, as an example, 
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transforms the signal into frequency domain and shows the different aspects of the signal 
(Cohen, 1995c).  A signal could be expressed as addition of sinusoids with different frequencies 
(Equation 3).  The spectrum (Fourier transform) of the signal s(t) is S(ω), and it can be obtained 
by Equation 4. 
Equation 3. Fourier expansion of signal (addition of sinusoids, ej?t, with different frequencies). 
€ 
s(t) = 12π S(ω)e
jωtdω∫ ?
Equation 4. Fourier analysis. 
 
The SBF signal, like many other biomedical signals, is non-stationary (Jan, Brienza, & 
Geyer, 2005).  This means the frequency characteristics of the SBF change over time.  
Traditional Fourier transform is able to analyze the signal in the frequency domain, however, it 
cannot distinguish when these frequencies occur during the measurement period (Cohen, 1995a).  
Short-time Fourier transform (STFT) is a method most widely used to overcome this difficulty 
by breaking the signal into short-time segments (windows), then a Fourier analysis is computed 
within each segment (Cohen, 1995b).  Equation 5 is the Fourier transform of signal s(τ) around 
time t, and h(τ-t) is the window function.  Spectral density, St(ω), is the outcome of the short 
time-Fourier transform.  It represents the energy at specific time and within specific frequency 
bands.  By analyzing the SBF data in both time and frequency domains, we could better 
understand the changes in control mechanisms with the cooling intervention. 
! 
S(") =
1
2#
s(t)e
$ j"t
dt%
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Equation 5. Fourier transform of signal s(τ) around time t, and h(τ-t) is the window function. 
 
! 
St (") =
1
2#
e
$ j"%
st (%)d%& =
1
2#
e
$ j"%
s(%)h(% $ t)d%&
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3.0  METHODS 
3.1 RESEARCH DESIGN 
A 3x3 mixed factorial design was used to test the interaction between types of local stimuli and 
levels of injury (Table 1).  The independent variable between groups was determined by the level 
of injury. The three levels are: 1) injury level at T6 and above (T6A), 2) injury level below T6 
(T6B), and 3) control (CTRL).  The independent variable within the subjects was determined by 
the test condition. The three test conditions are: 1) pressure only, 2) pressure with slow cooling (-
.33°C/min), and 3) pressure with fast cooling (-4°C/min).  All subjects were tested under the 
three conditions in a random order.  The Institutional Review Board (IRB) of University of 
Pittsburgh has approved the protocol of this study (IRB #PRO08060015). 
Table 1. 3x3 mixed factorial design. 
The numbers listed in each group/condition are the subject IDs. 
Test condition  
Pressure only Pressure + slow cooling Pressure + fast cooling 
T6A T6A01…T6A14 T6A01…T6A14 T6A01…T6A14 
T6B T6B01…T6B14 T6B01…T6B14 T6B01…T6B14 
Le
ve
l 
of
 
in
ju
ry
 
CTRL CTRL01…CTRL14 CTRL01…CTRL14 CTRL01…CTRL14 
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3.2 SUBJECTS 
A total of 36 adult subjects between 18 and 65 years old were recruited: 14 of them had no 
history of any neurological deficit, 14 had traumatic SCI with an injury level at T6 and above, 
and 8 had traumatic SCI with an injury level below T6.  All subjects were free of any 
cardiovascular, pulmonary diseases, diabetes mellitus, or hypertension.  Subjects with SCI did 
not have any current pressure ulcers at the sacral area, and experienced the injury at least one 
year prior to the experiment.  They were all wheelchair users and had no motor function at the 
sacral level.  To ensure that we tested the hypotheses of this study, only people with impaired 
autonomic function were recruited in the group of injury level at T6 and above.  The subjects 
were recruited through the Department of Physical Medicine and Rehabilitation, and Center of 
Rehabilitation Services at the University of Pittsburgh Medical Center (UPMC).  In addition, the 
research flyers were sent to the Human Engineering Research Laboratory, UPMC Center of 
Assistive Technology, Three Rivers Center of Independent Living, Keystone Paralyzed Veterans 
of America, Hope Network, Office of Vocational Rehabilitation and Three Rivers Adaptive 
Sports to distribute to potential subjects. 
3.3 PROCEDURES 
The study contained two parts: the screening and the experimental procedures.  The purpose of 
the screening procedure was to ensure that only people who meet the inclusion criteria of the 
study were recruited. The purpose of the experimental procedure was to perform the three test 
sessions on the subjects. 
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3.3.1 Screening procedure 
The screening procedure contained two parts: telephone screening and face-to-face screening 
procedures.  Potential participants underwent the telephone screening process first, and the 
following information was obtained: age, gender, general health status (history of hypertension, 
diabetes mellitus, cardiovascular, pulmonary disease), level of injury, duration of injury, 
autonomic function (symptoms of autonomic dysreflexia, awareness of need to empty bladder 
and sensation of bowel movement) and history of pressure ulcers and smoking.  Potential 
participants that met the criteria proceeded to a face-to-face screening procedure.  After 
completing the consent form, several measurements were taken to determine the eligibility of the 
participants, including blood pressure, heart rate, motor function, and questionnaires (for injury 
level at T6 and above only) on other autonomic functions (i.e. sensation of changes in 
temperature and ability to sweat).  The face-to-face screening procedure was performed in the 
Tissue Integrity Management (TIM) Laboratory at the Department of Rehabilitation Science and 
Technology, University of Pittsburgh.  All caffeinated food and drinks were prohibited 12 hours 
prior to the face-to-face screening procedure, and smokers refrained from smoking for at least 4 
hours prior to and during the experiment. 
3.3.2 Experimental procedure 
Once qualified for the study, the subject proceeded with the experimental procedure, which was 
performed in the TIM lab as well.  Room temperature was controlled at 22±1°C (71.6±1.8°F).  
Subjects were kept relaxed for at least 30 minutes in the laboratory to acclimate to the room 
temperature.  All subjects were randomly assigned to the order of the three experiment sessions 
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by allowing them to select one of six envelopes that contained one of the six different orders of 
the experiment sessions (Table 2). 
Table 2. Randomization of the order of test sessions. 
This table gives the six different orders of the three test sessions. 
Envelop Test session I Test Session II Test Session III 
A Pressure + Slow Cooling Pressure + Fast Cooling Pressure Only 
B Pressure Only Pressure + Slow Cooling Pressure + Fast Cooling 
C Pressure + Fast Cooling Pressure Only Pressure + Slow Cooling 
D Pressure + Slow Cooling Pressure Only Pressure + Fast Cooling 
E Pressure Only Pressure + Fast Cooling Pressure + Slow Cooling 
F Pressure + Fast Cooling Pressure + Slow Cooling Pressure Only 
 
During the experiment, the subjects lay prone on the mat table, and the tests were 
performed on the skin at the sacrum (Figure 3).  All three sessions had identical pressure 
application phases (Figure 4).  A pressure of 0.4 kPa (3 mmHg) was applied to the skin for the 
first five minutes, then the pressure was increased to 8 kPa (60 mmHg) for 20 minutes, and the 
pressure dropped back to 0.4 kPa of pressure for another 10 minutes.  Pressure of 0.4 kPa is 
equal to a light contact of the skin, while 8 kPa of pressure induced reactive hyperemia after 
pressure relief.  Local cooling was applied to the skin during the 20-minute interval of 8 kPa 
pressure.  A 30-60 minute washout period was given between each test session to avoid 
measuring the reactive hyperemic response from the previous test session (lasts about half of the 
time of tissue ischemia (Sprigle, et al., 2002)) as the baseline SBF for the next test session.  To 
ensure the safety of the subject, blood pressure and heart rate were measured before and after 
each test session, and the skin was checked after each session to see if any blanching occurred. 
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Figure 3. Test setting.  
The subjects lay prone on the mat table, and the tests were performed on the skin at the sacrum. 
 
Figure 4. Pressure application phases. 
A pressure of 0.4 kPa was applied to the skin for the first five minutes, then the pressure was 
increased to 8 kPa for 20 minutes, and the pressure dropped back to 0.4 kPa of pressure for 
another 10 minutes. Local cooling was applied to the skin during the 20-minute interval of 8 kPa 
pressure. 
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3.4 INSTRUMENTATION 
The instruments that were used in this study include: 1) computer-controlled indenter, 2) cooling 
system, and 3) laser Doppler flowmetry (LDF).  A computer interface created by the LabVIEW 
program (version 7.3, National Instrument, Austin, TX) was used to control both temperature 
and pressure (Figure 5) and displayed the SBF and temperature data in real-time for easy 
monitoring. 
 
Figure 5. Computer control interface created with LabVIEW. 
(A) pressure control panel, (B) pressure monitor, (C) SBF monitor, (D) temperature control, (E) 
temperature monitor, and (F) display of pressure control phase. 
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3.4.1 Computer-controlled indenter 
A computer-controlled indenter was used to maintain the pressure applied on the skin (Figure 6).  
From bottom to the top, it consists of a load cell (LC703, Omegadyne Inc., Sunbury, OH), a 
stage (MTR-13-E, National Aperture Inc., Salem, NH), a motor, and a lever system.  A strain 
gauge was located within the load cell.  Deformation of the strain gauge provided readings of the 
force that was applied on the skin.  A proportional-integral-derivative (PID) controller was 
embedded in the LabVIEW program.  The force read by the load cell was compared to the target 
value, and the moving speed of the stage was adjusted through the motor to maintain the pressure 
applied on the skin.  The lever system was counter-weighted to allow the indenter to 
accommodate the respiratory movement of the subjects during the test. 
 
Figure 6. Computer-controlled indenter. 
Left side: picture of computer controlled indenter (A) lever, (B) motor, (C) stage, (D) load cell, 
and (E) cooling system; Right side: schematic figure of the loading system. 
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3.4.2 Cooling system 
A thermoelectric (TE) cooling system (TE Technology, Traverse City, MI) was used to measure 
the skin temperature and apply local cooling at two different rates (Figure 7).  It was located 
below the load cell of the computer-controlled indenter, and it was the only component that 
contacted the skin directly.  A ball-and-socket joint was used to connect the cooling system to 
the load cell to provide more range of motion for the respiratory movement of the subjects.  The 
total cooling area of the skin was 1.8 cm2, and an opening (.2 cm in diameter) was located in the 
center of the cooling system to hold the LDF probe. 
The cooling system consists of four parts: the thermistor (modified from model MP2444), 
TE module (CH-38-1.0-0.8), heat radiator, and temperature controller board (TC-36-25 RS232).  
The TE module actively transfers heat from its cold side to the heat side through the Peltier 
effect.  The thermistor was attached to the cold side of the module, and the heat radiator was 
attached to the heat side with a conductive glue (TSE3941, Toshiba, Japan).  A mini fan was 
attached to the side of the radiator to assist the process of heat radiation.  Another PID controller 
embedded within the temperature controller board was used to control the skin temperature.  The 
parameters of the PID controller were set up as: proportional bandwidth = 1°C, integral gain = 
0.1 repeat/minute, and derivative gain = 0.1 minute.  The skin temperature measured by the 
thermistor was compared to the target value within the temperature controller, and the electrical 
power supplied to the TE module was adjusted based on the difference. 
Since the thermoelectric module was not thermally insulated and the cooling system was 
mainly made from copper, the thermoelectric module was preheated to 36°C for 20 minutes prior 
to the test to prevent cooling effect caused by the large heat sink capacity of the cooling system.  
After the thermoelectric module was preheated for 20 minutes, the preheating procedure was 
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turned off for 10 minutes before the probe was attached to the skin.  During the 10 minutes, the 
temperature was able to reach to a steady state temperature of 26°C (slightly lower than the 
normal skin temperature).  The probe was attached to the skin for another 10 minutes before the 
collection of any experimental data to ensure the thermistor was reading the actual skin 
temperature.  The experimental procedure did not start until the skin temperature reached a 
steady state (changes within 0.001°C/sec). 
 
Figure 7. Thermoelectric cooling system at the tip of the indenter. 
(A) mini fan, (B) heat sink, (C) opening for LDF probe, and (D) thermistor. 
3.4.3 Laser Doppler flowmetry 
Laserflo Blood Perfusion Monitor 2 (Vasamedics, Eden Prairie, MN) was used in the study to 
collect the SBF data.  The Softip pencil probe (P-435) was located in the center of the cooling 
system to measure the SBF throughout each test session (Figure 7).  This FDA-approved device 
provided non-invasive measurements of SBF at about 1 mm deep. 
 53 
3.5 OUTCOME MEASURES AND DATA ANALYSIS 
3.5.1 Outcome measures and SBF signal processing 
The outcome measures collected in this study include demographic data and experimental data.  
The demographic data collected included: age, body mass index [weight (kg)/ (height (m))2], 
autonomic function, injury level, years post-injury, and mean blood pressure (2/3 diastolic 
pressure + 1/3 systolic pressure).  The experimental data collected in this study included pressure 
applied on the skin, skin temperature and skin blood flow.  Figure 8 is a schematic figure 
showing all the outcome measures collected for statistical analysis in this study.  A signal 
processing procedure was performed to the skin blood flow data to get the time-domain 
parameters of the reactive hyperemia and the normalized spectral densities for statistical 
analyses.  The steps of signal processing are broken down in Figure 9. 
 
Figure 8. Schematic figure of outcome measures collected. 
Outcome	  measures	  
demographic	  data	  
skin	  temperature	  data	  
applied	  pressure	  data	  
skin	  blood	  5low	  data	  
time-­‐domain	  parameters	  of	  the	  the	  reactive	  hyperemia	  
normalized	  spectral	  densities	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Figure 9. Schematic figure of steps of signal processing. 
raw	  SBF	  data	  
down-­‐sampled	  SBF	  data	  
low-­‐pass	  5iltered	  SBF	  data	  
median-­‐5iltered	  SBF	  data	  
exponential	  curve-­‐5it	  of	  the	  SBF	  data	  
time-­‐domain	  parameters	  of	  the	  the	  reactive	  hyperemia	  
spectral	  analysis	  of	  SBF	  data	  
normalized	  spectral	  density	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Figure 10. Steps of skin blood flow signal processing. 
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Figure 9 is the schematic figure of signal processing, and Figure 10 shows the steps of 
SBF signal processing in one of the subjects’ data.  The MatLab program (The MathWorks, 
Natick, MA) was used to perform the signal processing. The raw SBF data were sampled at a 
rate of 20 Hz.  The data were then digitally down-sampled to 0.5 Hz (with anti-aliasing filter 
[Matlab routine: decimate]).  Since we were not interested in the vasomotion caused by heart rate 
and respiration, a tenth-ordered Chebyshev I low-pass filter (with the cut-off frequency at 
0.15Hz) was applied to the down-sampled SBF data.  The SBF data was then processed into two 
pathways, one was to select the time domain parameters of the reactive hyperemia and the other 
was to calculate the normalized spectral densities.  In order to remove large outliers (spikes) 
from the time series data, before selecting any time domain parameters of the reactive 
hyperemia, an 11-point-window (22 seconds) median filter was applied to the low-pass-filtered 
SBF data.  Least-squared model fit was used to fit a bi-exponential curve (Equation 6) to the 
filtered SBF data to calculate parameters: A1, A2, τ1, τ2 and B.  The five time-domain parameters 
of the reactive hyperemia were then calculated based on the fit equation.  The five time-domain 
parameters were the baseline, normalized peak SBF, time to peak SBF, half life and the 
perfusion area.  By taking derivative of Equation 6, time to peak (Equation 8) can be calculated 
when Equation 7 equals zero.  Peak SBF can be calculated by plugging Equation 8 into Equation 
6, and it’s shown in Equation 9.  To normalize the peak SBF and calculate the perfusion area and 
half life, baseline SBF should be calculated first.  Baseline SBF is the averaged value of skin 
blood flow data collected at the first five minutes of the test sessions, and it is given symbol 
€ 
S  
for following equations. 
Equation 6. Bi-exponential equation for curve fitting. 
 
! 
y(t) = A1e" t /#1 + A2e" t /#2 + B
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Equation 7. Derivative of equation 5. 
€ 
y'(t) = A1
−1
τ1
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ e−t /τ1 + A1
−1
τ2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ e− t /τ2  
Equation 8. Time to peak SBF calculated from equation 6. 
€ 
t =
ln − A2
τ2
×
τ1
A1
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
1
τ2
−
1
τ1
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
 
Equation 9. Peak SBF. 
€ 
ypeak = A1e
ln(−A2τ1 /A1τ2 )
1−τ1 /τ2 + A2e
ln(−A2τ1 /A1τ2 )
−1+τ2 /τ1 + B
= A1
−A2τ1
A1τ2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
τ2
τ2 −τ1
+ A2
−A2τ1
A1τ2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
τ1
τ2 −τ1
+ B
 
Equation 10. Normalized peak SBF. 
€ 
S  is the baseline SBF. 
€ 
ynormalized − peak = ypeak − S( ) S[ ] ×100%  
Equation 11. Perfusion area. 
€ 
S  is the baseline SBF. 
€ 
area = y(t) − S( )t=0
∞
∫ dt = A1 e−t /τ1dt + A2 e− t /τ2t=0
∞
∫ dt +t=0
∞
∫ (B − S)dtt=0
∞
∫
= A1 0 − (−τ1)( ) + A2 0 − (−τ2)( ) = A1τ1 + A2τ2
 
To obtain the normalized spectral densities of the SBF data, spectrogram was computed.  
Spectrogram is the magnitude-square of short-time Fourier transform (Equation 12) (Cohen, 
1995b).  A 256-sample Hanning window (512 seconds) was used to compute the spectrogram.  
This window length was selected so that the spectral main lobe of the window (~ 4/T, T=512 
seconds) was narrower than the width of the narrowest physiologic band (0.012 Hz, 
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corresponding to the metabolic band), thereby guarding against significant leakage of power 
from one physiologic band into its neighboring band.  For statistical purposes, the spectrogram 
was integrated within the three target frequency bands: 1) metabolic: 0.008-0.02 Hz, 2) 
neurogenic: 0.02-0.05 Hz, 3) myogenic: 0.05-0.15 Hz, and within two time intervals: 1) the five 
minutes prior to 8 kPa pressure application, and 2) the first five minutes after 8 kPa pressure 
removal.  The integrated spectrogram was normalized to the spectrogram at baseline (five 
minutes prior to 8 kPa pressure application) for the metabolic (Equation 13), neurogenic 
(Equation 14), and myogenic (Equation 15) frequency bands. 
Equation 12. Spectrogram. 
St(ω) is the Fourier transform of signal s(τ), and h(τ-t) is the window function. 
€ 
PSP (t,ω ) = St (ω )
2
=
1
2π e
− jωτs(τ )h(τ − t)dτ∫
2
 
Equation 13. Normalized metabolic spectral density. 
The metabolic spectral density (frequency range: 0.008-0.02Hz) during time period 1500-
1800 seconds is normalized to that during time period 0-300 seconds. 
€ 
Psp−ω = (T,ω )dTdωT =1500 sec
1800 sec
∫
ω =0.008Hz
0.02Hz
∫( ) (T,ω)dTdωT =0 sec300 sec∫ω =0.008Hz0.02Hz∫( )⎡ ⎣ ⎢ ⎤ ⎦ ⎥ ×100% 
Equation 14. Normalized neurogenic spectral density. 
The neurogenic spectral density (frequency range: 0.02-0.05Hz) during time period 1500-
1800 seconds is normalized to that during time period 0-300 seconds. 
€ 
Psp−ω = (T,ω )dTdωT =1500 sec
1800 sec
∫
ω =0.02Hz
0.05Hz
∫( ) (T,ω)dTdωT =0 sec300 sec∫ω =0.02Hz0.05Hz∫( )⎡ ⎣ ⎢ ⎤ ⎦ ⎥ ×100% 
Equation 15. Normalized myogenic spectral density. 
The myogenic spectral density (frequency range: 0.05-0.15Hz) during time period 1500-1800 
seconds is normalized to that during time period 0-300 seconds. 
€ 
Psp−ω = (T,ω )dTdωT =1500 sec
1800 sec
∫
ω =0.05Hz
0.15Hz
∫( ) (T,ω)dTdωT =0 sec300 sec∫ω =0.05Hz0.15Hz∫( )⎡ ⎣ ⎢ ⎤ ⎦ ⎥ ×100% 
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To compare the difference among subjects with different levels of neurological deficits, 
outcome measures generated from the time domain parameters were calculated.  The outcome 
measures for each cooling condition were calculated as percent changes in reactive hyperemia 
parameters from the pressure only condition.  The four parameters are listed as followed:   
Equation 16. Percent changes in normalized peak SBF with fast cooling. 
€ 
Δnomalized _ peakFast = NpSBFNon−cooling − NpSBFFast−cooling( ) NpSBFNon−cooling[ ] ×100%
 
Equation 17. Percent changes in perfusion area with fast cooling. 
€ 
ΔareaFast = areaNon−cooling − areaFast−cooling( ) areaNon−cooling[ ] ×100%
 
Equation 18. Percent changes in normalized peak SBF with slow cooling. 
€ 
Δnomalized _ peakSlow = NpSBFNon−cooling − NpSBFSlow−cooling( ) NpSBFNon−cooling[ ] ×100%
 
Equation 19. Percent changes in perfusion area with slow cooling. 
€ 
ΔareaSlow = areaNon−cooling − areaSlow−cooling( ) areaNon−cooling[ ] ×100%
 
3.5.2 Statistical analysis 
Descriptive analysis was used to see the distribution of the data and to determine the statistical 
analysis to use.  Parametric tests were used for normally distributed variables, while non-
parametric tests were used for non-normally distributed variables (Portney & Watkins, 2000).  
To ensure the consistency of the test instrument, two way repeated measures analysis of variance 
(ANOVA) was used to compare the applied pressure on the three test sessions and among the 
three groups of subjects.  In addition, to ensure the cooling capacity of the test system and that 
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skin temperature was the same before any temperature controls, two way repeated measures 
ANOVA was used to compare the skin temperature among all three test sessions and three 
groups of subjects before and at the end of the cooling application.  For hypotheses 1 a) and b), 
the variables to be compared within subjects included the four parameters of the reactive 
hyperemia (normalized peak SBF, perfusion area, time to peak SBF, half life) and the integrated 
spectrum during two intervals (baseline and the first 5 minutes of reactive hyperemia) within 
each of the three frequency bands.  To compare the four parameters of the reactive hyperemia, 
one way repeated measures ANOVA or Friedman test was used for parametric or nonparametric 
variables.  A p value <.05 was recognized as significant and Pair-wise comparison with 
Bonferroni correction was used if the repeated measures ANOVA or Friedman tests showed 
significant results.  To compare the integrated spectral densities change over time, paired t-test or 
Wilcoxon signed rank test was used to compare the difference between baseline and the first five 
minutes of reactive hyperemia with each group of subjects and each of the three test sessions.  
For hypotheses 2), one way ANOVA or Kruskal-Wallis test was used to compare the difference 
of percent changes with fast and slow cooling application from pressure only in normalized peak 
SBF, perfusion area, time to peak, and half life among the three subject groups. 
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4.0  RESULTS 
A total of 36 adult subjects between 18 and 65 years old were recruited: 14 of them had no 
history of any neurological deficit, 14 had traumatic SCI with an injury level at T6 and above, 
and 8 had traumatic SCI with an injury level below T6.  Since the reactive hyperemic response 
was the main outcome measurement of the study, the existence of reactive hyperemia was 
determined before any statistical analysis was computed.   
4.1 EXISTENCE OF REACTIVE HYPEREMIA 
According to the definition of reactive hyperemia, which is an increase in blood flow after 
ischemia relief that returns to the baseline value (Levick, 2003), the SBF after pressure relief that 
did not exceed the baseline value was considered as no reactive hyperemic response.   
Figure 11 is the summary of percentage of existence of reactive hyperemia in all three 
groups, and Table 3 provides details of each subject.  The reactive hyperemic response was not 
observed in the pressure only test session in one subject in the control group (CTRL_19), two 
subjects in T6A group (T6A_04 and T6A_11), and two subjects in the T6B group (T6B_01 and 
T6B_06).  These five subjects also did not have reactive hyperemia in both the fast and slow 
cooling test sessions.  For the rest of the subjects, five out of 13 subjects (38.46%) in control 
group, four out of 12 subject (33.33%) in T6A group, and two out of six subjects (33.33%) in 
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T6B group had no reactive hyperemic response with fast cooling. One out of 13 subjects (7.69%) 
in control group, two out of 12 subjects (16.67%) in T6A group, and one out of six subjects 
(16.67%) in T6B group had no reactive hyperemic response with slow cooling. 
Since the reactive hyperemic response was not induced in five subjects, the results of 
these five subjects were reported separately from the rest of the subjects.  In addition, data from 
the five subjects were not included for statistical analysis. 
 
Figure 11. Summary of the existence of reactive hyperemic response.  RH = reactive hyperemia. 
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Table 3. Details of existence of reactive hyperemic response in all subjects. 
Subject ID 
Test 
Session 
Reactive 
Hyperemia Subject ID 
Test 
Session 
Reactive 
Hyperemia Subject ID 
Test 
Session 
Reactive 
Hyperemia 
PF + PF - PF - 
PO + PO + PO - CTRL_01 
PS + 
T6A_01 
PS + 
T6B_01 
PS - 
PF - PF - PF + 
PO + PO + PO + CTRL _03 
PS + 
T6A_03 
PS + 
T6B_02 
PS + 
PF + PF - PF + 
PO + PO - PO + CTRL _04 
PS + 
T6A_04 
PS - 
T6B_03 
PS + 
PF + PF + PF - 
PO + PO + PO + CTRL _05 
PS + 
T6A_05 
PS - 
T6B_04 
PS + 
PF + PF - PF + 
PO + PO + PO + CTRL _06 
PS + 
T6A_06 
PS + 
T6B_05 
PS - 
PF + PF + PF - 
PO + PO + PO - CTRL _07 
PS + 
T6A_07 
PS + 
T6B_06 
PS - 
PF - PF + PF + 
PO + PO + PO + CTRL _09 
PS - 
T6A_08 
PS + 
T6B_07 
PS + 
PF - PF - PF - 
PO + PO + PO + CTRL _10 
PS + 
T6A_09 
PS + 
T6B_09 
PS + 
PF + PF + 
PO + PO + CTRL _11 
PS + 
T6A_10 
PS + 
PF - PF - 
PO + PO - CTRL _13 
PS + 
T6A_11 
PS - 
PF + PF + 
PO + PO + CTRL _14 
PS + 
T6A_12 
PS + 
PF - PF + 
PO + PO + CTRL _16 
PS + 
T6A_13 
PS + 
PF + PF + 
PO + PO + CTRL _17 
PS + 
T6A_14 
PS - 
PF - PF + 
PO - PO + CTRL _19 
PS - 
T6A_15 
PS +  
PF= pressure + fast cooling, PO= pressure only, PS= pressure + slow cooling. ‘+’ represents existence of reactive 
hyperemia, and ‘-’ represents no reactive hyperemia. 
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4.2 RANDOMIZATION OF THE ORDER OF TEST SESSIONS 
All subjects selected one of the six envelops for the purpose of randomizing the order of the 
three test sessions.  Table 4 shows the number of subjects within each group that underwent the 
six different orders of the test sessions.  The five subjects that did not have reactive hyperemia in 
all three test sessions were excluded in this table.  The order of the test sessions of these five 
subjects is presented in Table 5. 
Table 4. Number of subjects within each group that underwent each order of the three test sessions. 
This table excludes the subjects that did not have reactive hyperemia in all three test sessions. 
 
Group 
Order of Tests 
CTRL T6A T6B Total 
A: PSPFPO 1 2 2 5 
B: POPSPF - 4 1 5 
C: PFPOPS 4 2 1 7 
D: PSPOPF 3 3 2 8 
E: POPFPS 2 - - 2 
F: PFPSPO 4 3 2 9 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session, CTRL = control group, T6A = subjects with injury level at T6 and above, and T6B = subjects with 
injury level below T6. ‘-’ = no subjects with that order of the test sessions. 
Table 5. Number of subjects within each group that underwent each order of the three test sessions. 
This table only contains the five subjects that did not have reactive hyperemia in all three test 
sessions. 
 
Group 
Order of Tests 
CTRL T6A T6B Total 
A: PSPFPO - - - 0 
B: POPSPF - 1 - 1 
C: PFPOPS - - - 0 
D: PSPOPF 1 - 1 2 
E: POPFPS - - - 0 
F: PFPSPO - 1 1 2 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session, CTRL = control group, T6A = subjects with injury level at T6 and above, and T6B = subjects with 
injury level below T6. ‘-’ = no subjects with that order of the test sessions. 
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4.3 DEMOGRAPHIC DATA 
Table 6 is the summary of the subjects’ demographic data (excludes the five subjects that did not 
have reactive hyperemia in all three test sessions) and Table 7 shows the details of each subject’s 
demographic information.  There were more male subjects than female subjects in both T6A and 
T6B groups, and the averaged age of the two SCI groups were slightly higher than the control 
group.  The body mass index and the skinfold thickness were similar in all three groups. The 
mean blood pressure was slightly higher in the T6B group, while it was slightly lower in the T6A 
group.  The 14 subjects in group T6A all had symptoms of autonomic dysreflexia, no awareness 
of the need to empty bladder or bowel movement.  Although three of these 14 subjects had 
sensation preserved below the injury level, these 14 subjects self reported that they had no 
sensation of changes in temperature and reduced ability to sweat below the injury level. 
Table 6. Summary of subjects' demographic data. 
The results were presented in mean ± one standard deviation. This table excludes the subjects 
that did not have reactive hyperemia in all three test sections. 
Group 
Number of 
Subjects 
Recruited 
Gender Age 
Body Mass 
Index 
(kg/m2) 
Injury Duration 
(yrs) 
Mean Blood 
Pressure 
(mmHg) 
Skinfold 
Thickness 
(cm) 
CTRL 13 
6 Male 
7 Female 34.22 ± 11.45 22.77 ± 3.34 NA* 84.85 ± 8.48 0.71 ± 0.26 
T6A 12 
11 Male 
1 Female 37.69 ± 11.20 22.13 ± 3.68 13.00 ± 9.78 77.92 ± 7.74 0.69 ± 0.17 
T6B 6 
5 Male 
1 Female 36.81 ± 10.02 26.35 ± 4.05 10.50 ± 6.83 95.56 ± 8.48 0.85 ± 0.19 
*NA= not applicable. 
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Table 7. Detailed demographic information of all subjects. 
The five subjects that did not have reactive hyperemic response in all three test sessions were 
highlighted in bold. 
Subject Gender Age 
Body 
Mass 
Index 
(kg/m2) Race 
Injury 
Level 
Injury 
Duration 
(yrs) 
ASIA 
Grade Sensation 
Mean 
Blood 
Pressure 
(mmHg) 
Skinfold 
Thickness 
(cm) Smoker 
CTRL_01 Male 36.36 28.69 Caucasian - - - + 102.22 1.33 - 
CTRL _03 Male 48.17 23.01 Caucasian - - - + 87.56 0.51 - 
CTRL _04 Male 27.23 24.03 Asian - - - + 76.78 0.55 - 
CTRL _05 Male 49.93 24.41 Caucasian - - - + 88.00 0.63 - 
CTRL _06 Female 29.26 20.12 Asian - - - + 80.56 0.57 - 
CTRL _07 Female 19.43 24.13 Caucasian - - - + 77.33 0.81 - 
CTRL _09 Female 50.62 24.63 Caucasian - - - + 78.11 0.67 - 
CTRL _10 Male 19.82 20.64 Caucasian - - - + 84.11 0.74 - 
CTRL _11 Female 21.37 21.48 Caucasian - - - + 91.56 0.54 - 
CTRL _13 Male 25.14 27.26 Caucasian - - - + 91.56 0.66 - 
CTRL _14 Female 35.67 17.80 Asian - - - + 69.56 0.77 - 
CTRL _16 Female 44.03 22.66 Asian - - - + 90.67 1.12 - 
CTRL _17 Female 37.84 17.23 Caucasian - - - + 85.11 0.39 - 
CTRL _19 Male 28.14 23.01 Caucasian - - - + 88.44 0.50 - 
T6A_01 Male 20.71 16.82 A-A C5-C6 3 A - 81.56 0.52 - 
T6A_03 Male 43.29 26.17 Caucasian C7 18 A - 83.78 0.94 - 
T6A_04 Male 47.93 20.09 A-A T4-5 14 A - 94.44 0.95 - 
T6A_05 Female 26.71 20.34 Caucasian T4 2 A - 74.00 1.04 - 
T6A_06 Male 34.94 24.33 Caucasian C4 6 A - 73.78 0.62 - 
T6A_07 Male 48.27 23.67 Caucasian C5-6 23 A - 85.00 0.64 - 
T6A_08 Male 37.26 19.58 Caucasian C5-7 5 A - 71.11 0.51 - 
T6A_09 Male 50.27 25.63 Caucasian C5-6 31 A - 80.22 0.71 - 
T6A_10 Male 27.30 17.63 Caucasian C7 7 A - 66.89 0.49 - 
T6A_11 Male 28.90 26.58 Caucasian C6-T5 4 A - 79.11 0.66 - 
T6A_12 Male 32.07 20.63 Caucasian C6-7 4.5 B + 74.67 0.64 - 
T6A_13 Male 60.33 28.89 Caucasian C6 25 B + 70.00 0.74 - 
T6A_14 Male 35.42 22.38 Caucasian T4-6 16.5 A - 94.67 0.70 - 
T6A_15 Male 35.73 19.49 Caucasian C7-8 15 B + 79.33 0.74 - 
T6B_01 Male 52.59 25.09 Caucasian T7-8 34 B + 95.44 0.75 - 
T6B_02 Female 47.44 29.12 A-A T7 2 B + 106.22 0.87 + 
T6B_03 Male 41.84 22.04 Caucasian T11-12 17 A - 103.11 0.80 - 
T6B_04 Male 27.81 24.78 Caucasian T8 9 A - 98.67 0.59 - 
T6B_05 Male 45.85 30.54 Caucasian T6-7 16 A - 92.00 0.75 + 
T6B_06 Male 57.86 33.38 A-A T12 22 B + 106.67 0.86 - 
T6B_07 Male 22.75 29.98 Caucasian T8-9 3 A - 84.67 1.17 + 
T6B_09 Male 35.15 21.62 A-A T7 16 A - 88.67 0.91 - 
A-A = African-American. ASIA Grade is the grading standard of spinal cord injury from American Spinal Injury 
Association. ASIA Grade A= Complete: No motor or sensory function is preserved in the sacral segments S4-S5. 
ASIA Grade B = Incomplete: Sensory but not motor function is preserved below the neurological level and includes 
the sacral segments S4-S5. (American Spinal Injury Association, 2006) 
 67 
4.4 PRESSURE APPLIED ON THE SKIN 
4.4.1 Results from subjects that had reactive hyperemia in pressure only test session 
Figure 12, Figure 13, and Figure 14 are the average applied pressure on the skin of all subjects 
(excludes those without reactive hyperemia in all three test sessions) in the control, T6A and 
T6B groups for the three test sessions, respectively.  To show the comparison among the three 
different test sessions, the data was averaged every 30 seconds to plot the three figures.  By 
observing the three figures, the applied pressure was maintained at 3 mmHg during the first five 
minutes and the last 10 minutes of the test in all three test sessions of all three groups of subjects.  
From the fifth to the 25th minute of the test, the applied pressure was maintained at 60 mmHg 
during the 20 minutes in all three test sessions of all three groups of subjects.  Although the 
applied pressure oscillated slightly above and below the target value in subject groups T6A and 
T6B throughout the test, the applied pressure rapidly reached the target value. 
To compare the pressure applied on the skin, especially to ensure that the pressure 
applied on the skin to induce the reactive hyperemic response was the same in all participants, a 
two-way repeated measures ANOVA was used to compare the pressure during the three phases 
of the test (averaged during the first 5 minutes, the 20 minutes of 60 mmHg pressure application 
period, and the last 10 minutes of the test).  Table 8, Table 9 and Table 10 show the results of 
descriptive analysis (mean and standard deviation) and two-way repeated measures ANOVA of 
the applied pressure on the skin in the three groups during the three pressure application phases.  
The results showed that the pressure applied on the skin during the 60 mmHg pressure 
application was not significantly different among the three test sessions and the three groups of 
subjects (Table 9).  The applied pressure during baseline and reactive hyperemia were 
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significantly higher in the T6A and T6B groups, however the differences were small (within 1 
mmHg).  This may be due to the slight oscillation of pressure in the two SCI groups. 
Table 8. Mean and standard deviation of applied pressure on the sacral skin during baseline. 
Comparisons (p) Test Session 
 
 
Group 
PF PO PS Within 
Subject 
Between 
Group 
CTRL 3.00 ± 0.45 3.02 ± 0.41 3.11 ± 0.48 
T6A 3.97 ± 0.62 3.77 ± 0.70 3.52 ± 0.53 
T6B 3.64 ± 0.15 3.72 ± 0.26 3.60 ± 0.11 
.271 <.001* 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
Table 9. Mean and standard deviation of applied pressure on the sacral skin during 60mmHg of 
target pressure. 
Comparisons (p) Test Session 
 
 
Group 
PF PO PS Within 
Subject 
Between 
Group 
CTRL 57.36 ± 1.89 57.85 ± 2.46 57.48 ± 1.53 
T6A 58.65 ± 4.35 59.38 ± 5.05 59.84 ± 4.45 
T6B 60.05 ± 4.45 61.12 ± 2.89 60.54 ± 3.98 
.144 .177 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
Table 10. Mean and standard deviation of applied pressure on the sacral skin during reactive 
hyperemia. 
Comparisons (p) Test Session 
 
 
Group 
PF PO PS Within 
Subject 
Between 
Group 
CTRL 3.05 ± 0.53 2.98 ± 0.37 3.06 ± 0.42 
T6A 3.86 ± 0.78 3.92 ± 0.63 3.62 ± 0.60 
T6B 3.64 ± 0.21 3.73 ± 0.32 3.72 ± 0.19 
.670 <.001* 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 12. Average applied pressure during three test sessions on subjects with reactive hyperemia in 
control group. 
 
Figure 13. Average applied pressure during three test sessions on subjects with reactive hyperemia in 
T6A group. 
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Figure 14. Average applied pressure during three test sessions on subjects with reactive hyperemia in 
T6B group. 
4.4.2 Results from subjects with no reactive hyperemic response in all test sessions 
Figure 15, Figure 16 and Figure 17 are the average applied pressure on the skin of subjects with 
no reactive hyperemia in all three test sessions in the control, T6A and T6B groups for the three 
test sessions, respectively.  To show the comparison among the three different test sessions, the 
data was also averaged every 30 seconds to plot the three figures.  By observing the three 
figures, the applied pressure was maintained at 3 mmHg during the first five minutes and the last 
10 minutes of the test in all three test sessions of all three groups of subjects.  From the fifth to 
the 25th minute of the test, the applied pressure was slightly higher in the control group than in 
the other two test sessions; the average applied pressure was slightly lower than 60 mmHg in all 
three test sessions in the T6B group.  However, the applied pressure was maintained at 60 mmHg 
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during the 20 minutes in all three test sessions in the T6A group.  The applied pressure oscillated 
around the target value in all three groups, and the oscillation range of all three groups is slightly 
greater than that in the other 31 subjects (Figure 12, Figure 13 and Figure 14). 
 
Figure 15. Average applied pressure during three test sessions on the subject without reactive 
hyperemia in control group. 
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Figure 16. Average applied pressure during three test sessions on subjects without reactive 
hyperemia in T6A group. 
 
Figure 17. Average applied pressure during three test sessions on subjects without reactive 
hyperemia in T6B group. 
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4.5 SKIN TEMPERATURE 
4.5.1 Results from subjects that had reactive hyperemia in pressure only test session 
Figure 18, Figure 19, and Figure 20 are the average skin temperature from all subjects (excludes 
those without reactive hyperemia in all three test sessions) in the control, T6A, and T6B groups 
in all three test sessions, respectively.  To show the comparison among the three different test 
sessions, the data was averaged every 30 seconds to plot the three figures.  By observing the 
three figures, the skin temperature decreased about 0.5°C during the first five minutes in all three 
test sessions of all three groups of subjects.  The skin temperature reached 25°C within one 
minute of cooling application in the fast cooling test session in all three groups, and the skin 
temperature decreased at a slower rate and reached 25°C after 15 minutes of cooling application 
in the slow cooling test session in all three groups.  The skin temperature reached the baseline 
skin temperature rapidly after removal of cooling application in both fast and slow cooling test 
sessions in all three groups. 
To compare the skin temperature, especially to ensure the capability of the local cooling 
system on subjects with different levels of neurological deficit, a two-way repeated measures 
ANOVA was used to compare the skin temperature during the three phases of the test (the skin 
temperature averaged during the first 5 minutes, the skin temperature after 20 minutes of 60 
mmHg pressure application, and the skin temperature averaged during the last 10 minutes of the 
test).  Table 11, Table 12 and Table 13 show the results of descriptive analysis (mean and 
standard deviation) and two-way repeated measures ANOVA of the skin temperature in the three 
groups during the three pressure application phases.  The results showed that the skin 
temperature after 20 minutes of 60 mmHg of pressure application was significantly different 
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among test sessions; however, there was no significant difference among test groups (Table 12).  
Pair-wise comparisons showed that skin temperature after 20 minutes of 60 mmHg pressure 
application without cooling was significantly higher than for both fast (p<0.001) and slow 
cooling (p<0.001).  Although the skin temperature at the end of 60 mmHg pressure application 
was also significantly higher in slow cooling as compared to fast cooling (p<0.001), the 
differences were small (within 0.05°C).  The results showed that the baseline skin temperature 
was significantly different among test sessions and subject groups (Table 11).  However, the 
differences were small (0.5-1°C), and the baseline skin temperature did not affect the capacity of 
local cooling application to the subjects.  The results also showed that the skin temperature 
during reactive hyperemia was significantly different among test sessions, but not among subject 
groups (Table 13).  However, the differences were small (0.5-1°C). 
Table 11. Mean and standard deviation of skin temperature during baseline. 
Comparisons (p) Test Session 
 
 
Group 
PF PO PS Within 
Subject 
Between 
Group 
CTRL 28.34 ± 1.17 28.03 ± 0.58 27.83 ± 0.78 
T6A 28.24 ± 1.58 28.14 ± 0.94 27.94 ± 1.60 
T6B 29.86 ± 1.13 28.96 ± 0.79 29.09 ± 1.54 
.030* .037* 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
Table 12. Mean and standard deviation of skin temperature at the end of 60mmHg pressure. 
Comparisons (p) Test Session 
 
 
Group 
PF PO PS Within 
Subject 
Between 
Group 
CTRL 24.97 ± 0.02 28.16 ± 0.64 25.00 ± 0.01 
T6A 24.97 ± 0.02 27.78 ± 0.98 25.00 ± 0.01 
T6B 24.97 ± 0.02 28.61 ± 0.74 25.00 ± 0.00 
<.001* .123 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Table 13. Mean and standard deviation of skin temperature during reactive hyperemia. 
Comparisons (p) Test Session 
 
 
Group 
PF PO PS Within 
Subject 
Between 
Group 
CTRL 28.00 ± 1.00 27.59 ± 0.69 27.54 ± 0.60 
T6A 27.43 ± 0.91 27.21 ± 1.04 27.53 ± 1.20 
T6B 28.29 ± 0.88 28.04 ± 0.70 28.52 ± 1.03 
.039* .121 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
 
Figure 18. Averaged skin temperature during three test sessions on subjects with reactive hyperemia 
in control group. 
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Figure 19. Averaged skin temperature during three test sessions on subjects with reactive hyperemia 
in T6A group. 
 
Figure 20. Averaged skin temperature during three test sessions on subjects with reactive hyperemia 
in T6B group. 
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4.5.2 Results from subjects with no reactive hyperemic response in all test sessions 
Figure 21, Figure 22 and Figure 23 are the average skin temperature of subjects with no reactive 
hyperemia in all three test sessions in the control, T6A and T6B groups for the three test 
sessions, respectively.  To show the comparison among the three different test sessions, the data 
was also averaged every 30 seconds to plot the three figures.  By observing the three figures, all 
three figures showed similar trend of skin temperature changes as compared to the other 31 
subjects shown previously.  The skin temperature also decreased about 0.5°C during the first five 
minutes in all three test sessions of all three groups of subjects.  The skin temperature reached 
25°C within one minute of cooling application in the fast cooling test session in all three groups.  
The skin temperature decreased at a slower rate and reached 25°C after 15 minutes of cooling 
application in the slow cooling test session in T6A and T6B groups.  Since the baseline skin 
temperature was lower for the subject in the control group (Figure 21) as compared to the other 
subjects that had reactive hyperemia in the same group (Figure 18), the skin temperature reached 
25°C in a shorter period of time in the slow cooling test session.  The skin temperature reached 
the baseline skin temperature rapidly after removal of cooling application in both fast and slow 
cooling test sessions in all three groups. 
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Figure 21. Averaged skin temperature during three test sessions on the subject without reactive 
hyperemia in control group. 
 
Figure 22. Averaged skin temperature during three test sessions on subjects without reactive 
hyperemia in T6A group. 
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Figure 23. Averaged skin temperature during three test sessions on subjects without reactive 
hyperemia in T6B group. 
4.6 SKIN BLOOD FLOW 
Since breaking down the skin blood flow data into the target parameters provides more 
information to answer the research questions of this study, the data shown in this section contains 
only the parameters of the reactive hyperemia.  The filtered skin blood flow data with the least-
squared fit curves of all 36 subjects were plotted and attached as Appendix A of this dissertation. 
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4.6.1 Baseline SBF 
Figure 24 is the box plot (displays the median, quartiles, extreme values, and labels the outliers) 
of the baseline SBF in all subjects (excludes those without reactive hyperemia in all three test 
sessions).  To ensure that the baseline SBF is not a factor among test sessions and the three 
groups of subjects, a two-way repeated measures ANOVA was used to compare the baseline 
SBF.  The results showed that the baseline SBF was not significantly different among the three 
test sessions and the three groups of subjects (Table 14).  Figure 25 is the box plot of the baseline 
SBF in subjects with no reactive hyperemia in all three test sessions.  The baseline SBF of the 
subject in the control group was higher than those in the T6A and T6B group.  The baseline SBF 
of the subject in the control group was also higher when compared to the other subject in the 
same group that had reactive hyperemia, but this phenomenon was not observed in the T6A and 
T6B groups. 
Table 14. Mean and standard deviation of baseline SBF, and the results of the two-way repeated 
measures ANOVA. 
Comparisons (p) Test Session 
 
 
Group 
PF PO PS Within 
Subject 
Between 
Group 
CTRL (N=13) 6.78 ± 3.18 5.86 ± 3.14 6.58 ± 3.43 
T6A (N=12) 5.85 ± 2.97 6.13 ± 3.34 5.87 ± 2.85 
T6B (N=6) 3.59 ± 0.82 3.54 ± 1.20 4.84 ± 1.59 
.530 .146 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session??
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Figure 24. Box plots of baseline SBF in all subjects (excluding those without reactive hyperemia in all 
test sessions). 
 
Figure 25. Box plots of baseline SBF in subjects without reactive hyperemia in all test sessions. 
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4.6.2 Reactive hyperemic response compared within subjects 
4.6.2.1 Hypothesis 1a) and 1b): normalized peak 
Since descriptive analysis showed that the normalized peak SBF was not normally 
distributed, a Friedman test was used to compare the differences among the three test sessions.  
Figure 26 is the box plot of normalized peak among three test sessions from all subjects 
(excluding those without reactive hyperemia in all test sessions).  When comparing the three test 
sessions from all 31 subjects (Table 15), the Friedman test showed a significant difference 
among test sessions.  Pair-wise comparison showed that the normalized peak SBF in pressure 
only was significantly greater than that in pressure with fast cooling (p=0.014) but not with slow 
cooling (p=0.240).  In addition, the normalized peak SBF in pressure with slow cooling was 
close to significantly greater than that in pressure with fast cooling (p=0.057). 
Table 15. Mean and standard deviation of normalized peak SBF and the results of the Friedman test 
(N=31). 
Test Session 
 
Group 
PF PO PS Within Subject Comparisons (p) 
Mean ± Standard Deviation 61.18 ± 84.18 114.08 ± 108.12 89.88 ± 105.01 .015* 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 26. Box plots of normalized peak SBF in all subjects (excluding those without reactive 
hyperemia in all test sessions). 
 
To further investigate the difference among test sessions in all three subject groups, the 
Friedman test was computed on three groups separately.  Figure 27 is the box plot of the 
normalized peak among three test sessions plotted by groups.  Table 16 shows the results of 
descriptive statistics and the Friedman tests of three groups.  Although pressure with fast cooling 
had the lowest mean rank in all three groups, Friedman tests did not show significant differences 
among test sessions in all three groups.  The differences among test sessions were close to 
significant in the control group, and the pair-wise comparison (with Bonferroni correction: 
p<0.016 considered significant) showed that the normalized peak SBF in pressure only was close 
to significantly greater than that in pressure with fast cooling (p=0.023) and pressure with slow 
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cooling (p=0.033).  However, there was no significant difference in normalized peak SBF while 
comparing pressure with fast cooling and pressure with slow cooling. 
Table 16. Mean and standard deviation of normalized peak SBF and the results of the Friedman tests 
computed separately by group. 
Test Session 
 
 
Group 
PF PO PS Within Subject Comparisons (p) 
CTRL (N=13) 43.80 ± 62.93 117.15 ± 127.31 47.06 ± 48.87 .052 
T6A (N=12) 82.27 ± 110.66 108.36 ± 90.04 140.18 ± 139.02 .338 
T6B (N=6) 56.62 ± 64.74 118.84 ± 115.26 82.07 ± 83.66 .513 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session??
 
Figure 27. Box plots of normalized peak SBF by group in all subjects (excluding those without 
reactive hyperemia in all test sessions). 
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4.6.2.2 Hypothesis 1c) and 1d): perfusion area 
Since descriptive analysis showed that the perfusion area was not normally distributed, a 
Friedman test was used to compare the differences among the three test sessions.  Figure 28 is 
the box plot of perfusion area among three test sessions from all subjects (excludes those without 
reactive hyperemia in all test sessions).  When comparing the three test sessions from all 31 
subjects (Table 17), the Friedman test showed a significant difference among test sessions.  Pair-
wise comparison showed that the perfusion area in pressure only was significantly greater than 
that in pressure with fast cooling (p=0.004) but not with slow cooling (p=0.065).  In addition, the 
perfusion area in pressure with slow cooling was not significantly greater than that in pressure 
with fast cooling (p=0.131). 
Table 17. Mean and standard deviation of perfusion area and the results of the Friedman test (N=31). 
Test Session 
 
Group 
PF PO PS Within Subject Comparisons (p) 
Mean ± Standard Deviation 143.28 ± 262.12 311.25 ± 278.25 215.17 ± 311.39 .003* 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 28. Box plots of perfusion area in all subjects (excludes those without reactive hyperemia in all 
test sessions). 
To further investigate the difference among test sessions in all three groups, the Friedman 
test was computed on three groups separately.  Figure 29 is the box plot of the perfusion area 
among three test sessions plotted by groups.  Table 18 shows the results of descriptive statistics 
and the Friedman tests of three groups.  Friedman test showed that there was a significant 
difference among three test sessions only in the control group, and pair-wise comparison (with 
Bonferroni correction: p<0.016 considered significant) showed that the perfusion area of 
pressure only was significantly greater than that with slow cooling (p=0.016), and was close to 
significantly greater as compared to pressure with fast cooling (p=0.023).  The perfusion area 
was also not significantly different between fast cooling and slow cooling (p=.937).  Although 
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pressure with fast cooling had the lowest mean rank of perfusion area in all three groups, the 
Friedman test did not show significant differences among test sessions in the two SCI groups. 
Table 18. Mean and standard deviation of perfusion area and the results of the Friedman tests 
computed separately by group. 
Test Session 
 
 
Group 
PF PO PS Within Subject Comparisons (p) 
CTRL (N=13) 101.13 ± 175.69 261.94 ± 213.04 67.61 ± 78.30 .019* 
T6A (N=12) 212.11 ± 364.93 367.10 ± 300.51 370.04 ± 378.42 .174 
T6B (N=6) 96.93 ± 163.18 306.88 ± 378.33 225.11 ± 371.12 .513 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
 
Figure 29. Box plots of perfusion area by group in all subjects (excludes those without reactive 
hyperemia in all test sessions). 
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4.6.2.3 Other parameters: time to peak and half life 
To further characterize and understand the nature of the reactive hyperemia, time to the 
peak SBF and half life of the reactive hyperemia were compared among the three test sessions.  
Since both data sets were not normally distributed, the Friedman test was used to compare the 
differences among the three test sessions.  Figure 30 and Figure 32 are the box plots of the time 
to peak SBF and half life among the three test sessions from all subjects (excludes those without 
reactive hyperemia in all test sessions), respectively.  Only 17 subjects had reactive hyperemia in 
all three test sessions, and Friedman test did not show any significant differences among the 
three test sessions in either the time to peak SBF (Table 19) or half life (Table 21).  Figure 31 
and Figure 33 are the box plots of the time to peak and half life among three test sessions plotted 
by groups, respectively.  Table 20 and Table 22 show the results of descriptive statistics and 
Freidman tests of the time to peak and half of three groups, respectively.  There was also no 
significant difference among the test sessions with the subject groups analyzed separately. 
Table 19. Mean and standard deviation of time to peak and the results of the Friedman test (N=17). 
Test Session 
 
Group 
PF PO PS Within Subject Comparisons (p) 
Mean ± Standard Deviation 41.88 ± 27.99 60.00 ± 44.86 49.65 ± 32.27 .481 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 30. Box plots of time to peak SBF in all subjects (excludes those without reactive hyperemia in 
all test sessions. 
Table 20. Mean and standard deviation of time to peak and the results of the Friedman tests 
computed separately by group. 
Test Session 
 
 
Group 
PF PO PS Within Subject Comparisons (p) 
CTRL (N=8) 41.00 ± 36.63 34.25 ± 19.34 42.25 ± 19.32 .607 
T6A (N=6) 48.33 ± 20.49 80.33 ± 60.44 60.67 ± 40.07 .568 
T6B (N=3) 31.33 ± 15.01 88.00 ± 24.25 47.33 ± 49.17 .264 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 31. Box plots of time to peak by group in all subjects (excludes those without reactive 
hyperemia in all test sessions). 
Table 21. Mean and standard deviation of half life and the results of the Friedman test (N=17). 
Test Session 
 
Group 
PF PO PS Within Subject Comparisons (p) 
Mean ± Standard Deviation 542.00 ± 49.40 498.12 ± 122.03 451.53 ± 166.53 .080 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 32. Box plots of half life in all subjects (excludes those without reactive hyperemia in all test 
sessions). 
Table 22. Mean and standard deviation of half life and the results of the Friedman tests computed 
separately by group. 
Test Session 
 
 
Group 
PF PO PS Within Subject Comparisons (p) 
CTRL (N=8) 553.00 ± 36.63 502.25 ± 158.79 445.50 ± 187.91 .223 
T6A (N=6) 517.00 ± 68.11 488.67 ± 109.29 412.00 ± 176.00 .311 
T6B (N=3) 562.67 ± 15.01 506.00 ± 24.25 546.67 ± 49.17 .264 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 33. Box plots of half life by group in all subjects (excludes those without reactive hyperemia in 
all test sessions). 
4.6.2.4 Normalized spectral densities 
To understand the underlying vessel control mechanisms during reactive hyperemia, the 
SBF was broken down into three different frequency bands: metabolic, neurogenic, and 
myogenic.  Since the spectral density in all three frequency bands were not normally distributed, 
the Wilcoxon signed rank test was used to compare the changes in spectral density during 
reactive hyperemia as compared to the blood flow at baseline (before application of pressure). 
(a) Metabolic spectral density 
Figure 34 is the box plot of normalized metabolic spectral densities of all three test 
sessions from all subjects (excludes those with no reactive hyperemia in all test sessions).  Table 
23 shows the results of descriptive analysis and Wilcoxon signed rank tests or the normalized 
metabolic spectral densities.  The control group did not show any significant increase in 
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metabolic spectral density in all three test sessions.  In people with injury level above T6, the 
metabolic spectral density increased significantly in both the pressure only and pressure with 
slow cooling test sessions, but not in the pressure with fast cooling.  In people with injury level 
below T6, there was no significant increase in metabolic spectral density in all three test 
sessions.  Figure 35 is the box plot of metabolic spectral densities in subjects with no reactive 
hyperemia in all test sessions.  All five subjects had greater normalized metabolic spectral 
densities in pressure with fast cooling. 
Table 23. Mean and standard deviation (SD) of normalized metabolic spectral densities during 
reactive hyperemia. 
 The p values were the results of Wilcoxon signed rank tests that compared the spectral densities 
during reactive hyperemia to that during baseline. 
PF PO PS Test Session 
 
 
Group 
Mean ± SD p Mean ± SD p Mean ± SD p 
CTRL 132.43 ± 207.14 .552 417.54 ± 912.01 .279 110.47 ± 92.83 .701 
T6A 809.09 ± 1492.76 .136 622.40 ±1044.40 .019* 335.32 ± 382.62 .041* 
T6B 436.78 ± 832.09 .463 379.37 ± 446.12 .345 289.40 ± 482.15 .600 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 34. Box plots of normalized metabolic spectral density in all subjects (excludes those without 
reactive hyperemia in all three sessions). 
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Figure 35. Box plots of normalized metabolic spectral density in subjects with no reactive hyperemia 
in all test sessions. 
(b) Neurogenic spectral density 
Figure 36 displays the normalized neurogenic spectral densities of from all subjects 
(excludes those with no reactive hyperemia).  Table 24 shows the results of descriptive analysis 
and Wilcoxon signed rank tests or the normalized neurogenic spectral densities.  The control 
group showed a significant increase with pressure only but not with pressure with fast or slow 
cooling.  In people with injury level above T6, the neurogenic spectral density increased 
significantly in pressure with slow cooling but not in pressure with fast cooling, and it is close to 
significant in pressure only.  In people with injury level below T6, there was no significant 
increase in neurogenic spectral density in all three test sessions.  Figure 37 is the box plot of 
neurogenic spectral densities in subjects with no reactive hyperemia in all test sessions.  Subjects 
in the control and T6B groups had greater normalized neurogenic spectral densities in pressure 
with fast cooling. 
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Table 24. Mean and standard deviation (SD) of normalized neurogenic spectral densities during 
reactive hyperemia. 
The p values were the results of Wilcoxon signed rank tests that compared the spectral densities 
during reactive hyperemia to that during baseline. 
PF PO PS Test Session 
 
 
Group 
Mean ± SD p Mean ± SD p Mean ± SD p 
CTRL 83.53 ± 78.35 .345 323.06 ± 413.57 .046* 181.03 ± 225.17 .650 
T6A 355.18 ± 609.82 .530 317.97 ± 305.51 .071 259.83 ± 225.99 .006* 
T6B 405.97 ± 678.18 .345 291.84 ± 362.25 .753 166.61 ± 207.83 .753 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
 
Figure 36. Box plots of normalized neurogenic spectral density in all subjects (excludes those without 
reactive hyperemia in all test sessions). 
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Figure 37. Box plots of normalized neurogenic spectral density in subjects with no reactive 
hyperemia in all test sessions. 
(c) Myogenic spectral density 
Figure 38 is the box plot of normalized myogenic spectral densities of all subjects 
(excludes those with no reactive hyperemia in all test sessions).  Table 25 shows the results of 
descriptive analysis and Wilcoxon signed rank tests of the normalized myogenic spectral 
densities of the normalized myogenic spectral densities.  The control group showed that the 
increase in myogenic spectral density is close to significant in pressure only, but not in pressure 
with fast or slow cooling.  In people with injury level above T6, the myogenic spectral density 
increased significantly in pressure only and pressure with slow cooling but not in pressure with 
fast cooling.  In people with injury level below T6, there was no significant increase in myogenic 
spectral density in all three test sessions.  Figure 39 is the box plot of myogenic spectral densities 
in subjects with no reactive hyperemia in all test sessions.  One of the subjects in each group had 
greater normalized myogenic spectral densities in pressure with fast cooling. 
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Table 25. Mean and standard deviation (SD) of normalized myogenic spectral densities during 
reactive hyperemia. 
The p values were the results of Wilcoxon signed rank tests that compared the spectral densities 
during reactive hyperemia to that during baseline. 
PF PO PS Test Session 
 
 
Group 
Mean ± SD p Mean ± SD p Mean ± SD p 
CTRL 105.04 ± 112.89 .650 298.93 ± 321.57 .064 125.85 ± 119.70 .552 
T6A 258.51 ± 340.87 .308 326.32 ± 318.41 .034* 208.99 ± 101.54 .008* 
T6B 291.31 ± 423.76 .345 213.08 ± 188.81 .345 145.80 ± 181.66 .917 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
 
Figure 38. Box plots of normalized myogenic spectral density in all subjects (excludes those without 
reactive hyperemia in all test sessions). 
 99 
 
Figure 39. Box plots of normalized myogenic spectral density in subjects with no reactive hyperemia 
in all three test sessions. 
4.6.3 Reactive hyperemic response compared among groups 
Since the percentage decrease of normalized peak SBF, perfusion area, time to peak SBF and 
half life were not normally distributed, the Kruskal-Wallis test was used to compare the 
differences among the three subject groups.  Due to the fact that there was no significant changes 
in time to peak SBF and half life with the local cooling application, no further statistical analysis 
was computed for the percent decrease of these two parameters to compare among groups.  ?
4.6.3.1 Hypotheses 2 a) b) e) and f): decreased normalized peak SBF with local cooling 
Figure 40 is the box plot of the percentage change of normalized peak SBF in pressure 
with fast and slow cooling subtracted from pressure only in all three groups.  Table 26 shows the 
results of descriptive analysis and Kruskall-Wallis tests in all subjects (excludes those with no 
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reactive hyperemia in all test sessions).  There was no significant difference among the three test 
groups in the percent change of normalized peak SBF. 
Table 26. Mean and standard deviation (SD) of percent change of normalized peak SBF in all 
subjects (excludes those with no reactive hyperemia in all test sessions). 
The p values were the results of Kruskal-Wallis tests. 
(PO-PF)/PO (%) (PO-PS)/PO (%) Test Session 
 
 
Group 
Mean ± SD p Mean ± SD p 
CTRL (N=13) 29.63 ± 125.06 5.89 ± 126.26 
T6A (N=12) -105.90 ± 507.67 -59.41 ± 164.99 
T6B (N=6) -6.61 ± 151.34 
.800 
-44.45 ± 153.72 
.543 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
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Figure 40. Box plots of changes in normalized peak SBF from pressure only in all three groups. 
4.6.3.2 Hypotheses 2 c) d) g) and h): decreased perfusion area with local cooling 
Figure 41 is the box plot of the percentage change of perfusion area in pressure with fast 
and slow cooling subtracted from pressure only in all three groups.  Table 27 shows the results of 
descriptive analysis and Kruskall-Wallis tests in all subjects (excludes those with no reactive 
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hyperemia in all test sessions).  There was no significant difference among the three test groups 
in the percent change of perfusion area. 
 
Table 27. Mean and standard deviation (SD) of percent change of perfusion area in all subjects 
(exclude those with no reactive hyperemia in all test sessions). 
The p values were the results of Kruskal-Wallis tests. 
(PO-PF)/PO (%) (PO-PS)/PO (%) Test Session 
 
 
Group 
Mean ± SD p Mean ± SD p 
CTRL (N=13) -136.23 ± 745.39 -159.67 ± 575.67 
T6A (N=12) -356.34 ± 1309.43 -79.35 ± 230.82 
T6B (N=6) -6.57 ± 171.51 
.782 
-114.48 ± 362.44 
.514 
PS = pressure + slow cooling test session, PF = pressure + fast cooling test session, PO = pressure only test 
session. 
 103 
 
Figure 41. Box plots of changes in perfusion area from pressure only in all three groups. 
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5.0  DISCUSSION 
5.1 SUMMARY OF MAJOR FINDINGS 
Major findings from this study fall under four main categories: 1) the capability of controlling 
and maintaining the test conditions (section 5.2), 2) the effectiveness of different cooling rates on 
healthy controls (section 5.3), 3) the effectiveness of different cooling rates on people with SCI 
(section 5.4), and 4) the differences in cooling effects on people with different levels of 
neurological deficit (section 5.5).  Results from this study suggest that the instruments used in 
this study were capable of providing pressure and temperature control on the skin.  In addition, 
the integrated system was capable of measuring the reactive hyperemic response for comparison 
among subjects and test sessions.  Results from the reactive hyperemic response suggest that 
local skin cooling provides a protective effect on the skin during ischemia in people without SCI.  
In people with injury level at T6 and above, this phenomenon was not observed in the time 
domain parameters of the reactive hyperemia, but was observed in the spectral densities.  For 
comparisons among groups of changes in reactive hyperemia with local skin cooling, the lack of 
difference might be due to the small changes of reactive hyperemia with cooling application in 
people with SCI and the reduced hyperemic response after injury.  Details of each main category 
are listed in the following sections. 
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5.2 TEST CONDITIONS 
This study recruited a convenient sample of people with different levels of SCI.  The majority of 
the subjects were males, and the recruitment sample is consistent with that reported by the CDC 
(Centers for Disease Control and Prevention, 1998).  The test instrument of this study was 
modified from our previous pilot study that tested only young healthy adults (Tzen, et al., 2010).  
The consistent pressure control in all three test sessions and subject groups indicated that this 
system is capable of maintaining the same amount of pressure on people with different levels of 
neurological deficits.  The movement artifacts (oscillation in pressure) by subjects with SCI were 
corrected quickly throughout the tests.  The thermoelectric cooling system used in this study is 
the same as the one used in our pilot study as well.  Results from this study show that the 
modified test system is capable of controlling the skin temperature at two different cooling rates 
in all subjects.  In addition, both fast and slow cooling significantly reduces skin temperature as 
compared to that with pressure only.   
5.3 EFFECTIVENESS OF DIFFERENT COOLING RATES IN CONTROL GROUP 
Reactive hyperemia has been widely used in previous studies (Hagisawa, et al., 1994; V. 
Schubert & Fagrell, 1991b; Sprigle, et al., 2002) to investigate tissue viability and micro-
vascular function.  Time domain parameters including normalized peak SBF and perfusion area 
have been proven to represent different characteristics of this physiological response.  The 
normalized peak SBF is the maximum percent increase of SBF after pressure relief.  It was 
related to the extent of vasodilation during the reactive hyperemia (Hagisawa, et al., 1994).  A 
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previous study suggested that this parameter provided information of the severity of tissue 
ischemia.  Matsubara et al. (1998) induced the reactive hyperemic response with the same 
amount of pressure but with different amounts of time.  They found that the peak SBF was 
significantly higher with longer period of tissue ischemia.  The perfusion area was the total 
increase in SBF after the tissue ischemia.  Previous studies suggested that this increase in blood 
flow was to erase the oxygen/nutrition debt of the ischemic tissue (Levick, 2003) and this 
parameter could represent the metabolic repayment of the tissue (Hagisawa, et al., 1994). 
Results from people without SCI showed that both fast and slow cooling reduced the 
reactive hyperemic response.  Thirteen of the subjects had reactive hyperemia in the pressure 
only test session. Given that the pressure application phase was consistent and the baseline SBF 
was not significantly different among test sessions, the absence of a reactive hyperemic response 
in the fast and/or slow cooling sessions of these subjects was mainly due to the local cooling 
application.  Results of decreased normalized peak SBF with both fast and slow cooling suggests 
that the tissue ischemia was less severe with local skin cooling.  This result was consistent with 
our pilot study that compared the normalized peak SBF after cooling (25°C) and non-cooling on 
young healthy adults (Tzen, et al., 2010) and another animal study that compared the normalized 
peak SBF after mild hypothermia (34°C) and with core temperature (37°C) on pig coronary 
artery (Olivecrona, Gotberg, Harnek, Van der Pals, & Erlinge, 2007).  In addition, results of 
decreased perfusion area with both fast and slow cooling suggested that the metabolic demand 
during both cooling sessions was smaller as compared with no cooling.  This finding is 
consistent with that for the normalized peak SBF.  A previous study found that the tissue 
metabolic rate depends on the surrounding temperature of the tissue (Ruch & Patton, 1965), and 
a 1°C decrease of temperature causes about a 10% reduction in tissue metabolic rate.  Results 
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from this study support the finding that tissue metabolism depends on tissue temperature.  
Although another previous study found that local skin fast cooling but not slow cooling induced 
an initial vasodilation (Yamazaki, et al., 2006), findings from this study did not show any 
significant differences in reactive hyperemia response between two cooling rates.  One possible 
explanation may be that the initial vasodilation was not obvious when the skin was loaded.  
Another possible explanation may be that the initial cold-induced vasodilation does not last for a 
long period of time as compared to the time with loading.  In the study that discovered the 
differences in initial vasodilation between two cooling rates, the researchers did not discover 
how long the initial vasodilation lasted.  Finding from this study suggest that the blood supply 
during mechanical loading was not significantly different between the two cooling rates.    
The underlying mechanism of blood flow mediation in the control group may be the 
result of neurogenic mechanisms. The metabolic spectral density did not show any significant 
changes during reactive hyperemia in the control group; this was consistent with the findings in 
our pilot study (Tzen, et al., 2010).  However, the results conflict with a previous study using 
wavelet analysis to examine the blood flow signal in frequency domain.  Li et al. investigated the 
spectrum of the reactive hyperemic response in people with and without SCI.  They found that 
the normalized power spectrum increased significantly in metabolic, neurogenic and myogenic 
frequency bands in healthy controls, but only in metabolic frequency bands in SCI (Li, Leung, 
Tam, & Mak, 2006).  The different findings from this study and the previous study may be due 
to different amount of external pressure that is applied on the skin (Li et al. used twice the 
amount of pressure than this study). 
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5.4 EFFECTIVENESS OF DIFFERENT COOLING RATES IN PEOPLE WITH SCI 
There was no significant difference in normalized peak SBF and perfusion area among test 
sessions in people with spinal cord injury.  This finding is in contrast with that in the control 
group and may be due to a reduced reactive hyperemic response after injury.  Schubert and 
Fagrell (1991b) investigated the reactive hyperemic response in people with and without SCI and 
found that people with SCI had significantly lower perfusion area at the sacrum as compared to 
the healthy controls.  Hagisawa et al. (1994) also investigated the reactive hyperemic response in 
people with SCI and found that the increase in blood content was significantly reduced in people 
with SCI as compared to the control group.  Olive, McCully & Dudley (2002) investigated the 
reactive hyperemic response on people with incomplete SCI.  They found that the normalized 
peak flow after 2 and 4 minutes of ischemia was significantly lower in people with SCI as 
compared with the control groups.  The reduced reactive hyperemic response suggested that the 
vascular capacity of dilation was decreased in this population (Hagisawa, et al., 1994), and the 
tissue sensitivity of ischemia may decrease after injury (Olive, et al., 2002). 
The changes in vascular responses in people with SCI may be caused by increased 
vascular resistance after the injury.  Kooijman (2008) found that the structural changes and 
functional adaptation of the vascular response after injury cause the alteration in vascular 
response in people with SCI.  The reactive hyperemic response is mediated by several 
physiological mechanisms, including the accumulation of endothelial vasodilators (Engelke, 
Halliwill, Proctor, Dietz, & Joyner, 1996), sensory reflex (Larkin & Williams, 1993; Lorenzo & 
Minson, 2007), and smooth muscle activity (Koller & Bagi, 2002) that modulate this local 
vascular response.  The reduced reactive hyperemic response in people with SCI might be caused 
by the impaired β-adrenergic vasodilation, reduced nitric oxide release or endothelium sensitivity 
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of the nitric oxide (Olive, et al., 2002).  However, there were no studies provide information of 
how much (e.g. percentage) each physiological mechanism contributes to the reactive hyperemic 
response.  Furthermore, there are no studies that investigated ‘how much the reactive hyperemia 
changes’ when another stimulus in addition to pressure was added during the tissue ischemia in 
this population.  Due to the reduced vasodilation during reactive hyperemia and the unknown 
percentage of each physiological mechanism that contributes to the reactive hyperemic response, 
the effectiveness of local cooling on tissue viability in this population may be masked by a 
combination of changes in different physiological responses. 
The analysis of time domain parameters of the reactive hyperemia is augmented by the 
analysis of spectral density to provide information on specific physiological control mechanisms 
of the SBF.  Time frequency analysis has been used in previous studies to investigate the control 
mechanisms of vascular response during different pressure application patterns (Jan, Brienza, 
Geyer, & Karg, 2008) and thermoregulation (Geyer, et al., 2004). 
The metabolic spectral density is related to the vasodilation response caused by the 
accumulation of endothelial vasodilators (Stefanovska, et al., 1999).  The increased metabolic 
spectral density only in people with injury level at T6 and above during pressure only and 
pressure with slow cooling suggested that the accumulation of the endothelial vasodilator during 
this two sessions may be more obvious than that observed in fast cooling.  One possible 
explanation that the metabolic spectral density increased significantly in people with injury level 
at T6 and above might be because the tissue metabolism in people with SCI is different from that 
in healthy controls.  To date, studies that investigated the risk of people with SCI in developing 
pressure ulcers focused mainly on how much the interface pressure (Brienza & Karg, 1998) or 
the sub-dermal tissue stress differ from those that are not at risk of pressure ulcers (Linder-Ganz, 
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et al., 2008).  One study that investigated the resting metabolic rate of people with paraplegia 
showed that the resting metabolic rate of this population without pressure ulcers was 
significantly lower than that with pressure ulcers (Alexander, Spungen, Liu, Losada, & Bauman, 
1995).  In addition, the resting metabolic rate in healthy people with paraplegia was lower than 
the ambulatory individuals.  Findings from this study raised a question that the tissue metabolism 
during prolonged pressure and changes in skin temperature might be different in people with 
SCI, and further investigation in this topic may contribute to the understanding of physiological 
changes of soft tissue under prolonged pressure. 
The increased neurogenic spectral density in this population, however, was unexpected.  
Bracic and Stefanovska (Bracic & Stefanovska, 1998) found that the power spectrum within the 
neurogenic frequency band was absent with local anesthesia and sympathectomy.  The changes 
in the neurogenic spectral density indicated that the part of the local nerve response on vascular 
control was preserved in people with SCI.  A previous study blocked the α-adrenoceptor on 
people with and without SCI and found that the vascular resistance was reduced significantly in 
both population (Kooijman, Rongen, Smit, & Hopman, 2003).  This suggested that the α-
adrenergic tone was preserved after injury, and this response may be caused by the local reflex 
(probably the spinal sympathetic reflex and venoarteriolar reflex). 
The myogenic spectral density reflects the smooth muscle activity caused by changes in 
vascular tone.  Results of this study suggested that the endothelial vasodilation response in 
people with impaired autonomic nervous systems could still induce the smooth muscles 
surrounding the capillaries to maintain the vascular tone.  Further investigation of the percentage 
of the myogenic control mechanism may help to understand why the changes during reactive 
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hyperemia were observed in the spectral density but this difference was not as evident in the time 
domain parameters. 
5.5 DIFFERENCES IN COOLING EFFECTS ON PEOPLE WITH VARIOUS 
LEVELS OF NEUROLOGICAL DEFICITS 
There was no significant difference in the reduction of reactive hyperemia with cooling 
application among the three groups.  The lack of differences may be due to two reasons.  First, 
from the results of hypotheses 1, the differences among test sessions were not obvious in subjects 
with SCI; therefore comparison of the percentage changes from pressure only did not show any 
differences among the groups with different levels of neurological deficit.  Secondly, the percent 
decrease of reactive hyperemia with local cooling stimuli might be affected by the reduced 
reactive hyperemic response in people with SCI.  As described in previous paragraphs, the 
reactive hyperemic response may be reduced after injury due to changes in vessel structures and 
functional adaptation (Kooijman, 2008).  In addition, the percentage of different vascular control 
mechanisms may alter after injury.  For example, Kooijman et al. (2007).found that the 
myogenic control mechanism dominated the local vasoconstriction response in people with SCI   
They examined the vascular resistance of lower limb under two conditions: limb dependency and 
cuff inflation.  The vasoconstriction response during limb dependency depends on the myogenic 
vasoconstriction and the venoarteriolar reflex, while the response during cuff inflation depends 
on venoarteriolar reflex only.  They found that the vascular resistance of the lower limb 
increased significantly in people with SCI during limb dependency, however this phenomenon 
was not recognized during cuff inflation.  This suggested that the myogenic controlled 
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vasoconstriction dominated the local vasoconstriction response in people with SCI.  
Nevertheless, to date, there are no data on how much the myogenic response contributes to the 
vascular control during reactive hyperemia, and there are also no data on how much the 
myogenic control mechanism increases in the vascular control as compared to the other 
physiological mechanisms. 
The main differences observed among groups were in the time domain parameters and 
the spectral densities of the reactive hyperemia.  Findings from the control group suggested that 
both cooling rates decreased the severity of tissue ischemia and the metabolic demand.  In the 
control group, the significant changes in SBF after the release of tissue ischemia in the test 
session without cooling was mainly mediated by the neurogenic and myogenic control 
mechanisms.  On the contrary, in subjects with injury level at T6 and above, although changes in 
skin blood flow during reactive hyperemia was not obvious, spectral densities showed that the 
endothelial-related vasodilation (possibly nitric oxide and endothelium-derived hyperpolarizing 
factor (Bellien, et al., 2006; Lorenzo & Minson, 2007)) during reactive hyperemia increased with 
pressure only and pressure with slow cooling test sessions.  Results from this study suggest that 
local skin cooling provided a protective effect on people without SCI and people with SCI at T6 
and above.  Investigation of skin blood flow using time domain parameters and spectral densities 
provided more information on the tissue response to ischemia.  In addition, use of the two 
analysis approaches together improves the understanding of vascular control in people who 
encounter physiological changes due to disease and injury.   
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5.6 SUBJECTS WITH NO REACTIVE HYPEREMIA IN ALL TEST SESSIONS 
In general, reactive hyperemic response could be induced at pressure above 50 mmHg for about 
3 to 15 minutes on the human forearm (Cracowski, et al., 2006).  However, the amount of 
pressure used to induce the reactive hyperemic response differed from person to person.  For 
example, Schubert and Fagrell (1991b) investigated the reactive hyperemic response on people 
with and without SCI and showed that the amount of pressure required to occlude the sacral SBF 
in people with SCI was significantly lower than that in the control group.  The goal of this study 
was not to occlude the sacral SBF completely.  Instead, this study created a pressure application 
phase that was similar to the clinical setting with slightly lower amount of pressure (Brienza, et 
al., 2001) to prevent any harmful effect caused by prolonged pressure.  Pressure of 60 mmHg 
was used in our pilot study on young healthy adults, and it was sufficient to induce reactive 
hyperemic response in all subjects (Tzen, et al., 2010).  Since the amount of pressure required to 
induce reactive hyperemic response differs from person to person, 60 mmHg of pressure may not 
be enough to induce the reactive hyperemic response in the five subjects in this study that did not 
have reactive hyperemia in all three test sessions.   
5.7 LIMITATIONS 
There were several limitations of this study.  The sample size of the T6B group did not reach the 
target number of recruitment, and the differences within or between groups may be affected.  
There were no test performed on the subjects to ensure that caffeinated food were not consumed 
12 hours prior to the test, and there were also no test to check if the smokers actually refrained 
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from smoking four hours prior to the test.  In addition, all medical history was self-reported and 
there may be recall bias involved when subjects reported the information.  Last, although the 
possible mechanisms that contribute to vascular controls were discovered, the exact substances 
or neurotransmitters of each mechanism were not fully identified.  Future studies investigating 
the percentage of each substance that contributes to the vascular control in subjects with different 
levels of neurological deficit will help to understand the changes that occur after spinal cord 
injury. 
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6.0  CONCLUSION 
This study is the first to investigate the effectiveness of local fast and slow cooling on 
people that are at risk of pressure ulcer development.  The results suggest that local fast and slow 
cooling both had a protective effect on the skin during ischemia in healthy controls.  In subjects 
with injury level at T6 and above, spectral density data suggest that the endothelial vasodilation 
was most obvious during pressure only and pressure with slow cooling; indicating that the 
accumulation of endothelial vasodilators increased significantly during ischemia in these two 
sessions but not with fast cooling.  
The results from this research support previous animal and human study findings that 
local skin cooling is beneficial to the tissue during prolonged pressure.  In addition, this study 
supports that analyzing the SBF signal in the frequency domain using time-frequency analysis is 
helpful in understanding the underlying mechanisms of circulatory control in people with 
different levels of neurological deficits.  Findings from this study will help to justify the 
development of support surfaces with microclimate controls for weight-bearing soft tissues.  In 
addition, investigation of the changes in tissue metabolism during tissue loading and the local 
smooth muscle control of the microcirculation may contribute to the understanding of the risk of 
pressure ulcer development in people with SCI. 
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APPENDIX A 
SKIN BLOOD FLOW EXPONENTIAL CURVE FITTING 
All figures are labeled with subject ID and test sessions (e.g. C=Control, A=T6A, B=T6B, 
PF=fast cooling, PO= pressure only, PS=slow cooling).  Blue dots show the filtered SBF data, 
and the red line show the fit curve of the data.  Baseline SBF of each test session and subject was 
listed for comparison.  Test sessions with no reactive hyperemic response are plotted with the 
full length of the test to show that there was actually no hyperemic response as compared with 
baseline value. 
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Subject CTRL_01: baseline SBF: PF= 2.50, PO= 4.13, PS= 4.83 
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Subject CTRL_03: baseline SBF: PF=11.16, PO= 5.70, PS= 3.78 
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 120 
Subject CTRL_04: baseline SBF: PF=4.77, PO= 4.38, PS= 4.97 
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Subject CTRL_05: baseline SBF: PF=4.09, PO= 6.65, PS= 3.47 
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 123 
Subject CTRL_06: baseline SBF: PF=6.63, PO= 2.78, PS= 2.23 
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Subject CTRL_07: baseline SBF: PF=5.23, PO= 6.31, PS= 5.40 
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Subject CTRL_09: baseline SBF: PF=5.98, PO= 2.46, PS= 9.33 
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Subject CTRL_10: baseline SBF: PF=8.10, PO= 8.75, PS= 8.25 
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Subject CTRL_11: baseline SBF: PF=5.17, PO= 8.20, PS= 5.83 
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Subject CTRL_13: baseline SBF: PF=8.47, PO= 7.59, PS= 6.11 
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 132 
Subject CTRL_14: baseline SBF: PF=3.99, PO= 2.82, PS= 5.55 
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Subject CTRL_16: baseline SBF: PF=8.00, PO= 3.02, PS= 11.11 
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 135 
Subject CTRL_17: baseline SBF: PF=14.04, PO= 13.40, PS= 14.66 
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Subject CTRL_19: baseline SBF: PF=13.13, PO= 12.65, PS= 14.46 
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 138 
Subject T6A_01: baseline SBF: PF=3.25, PO= 7.79, PS= 3.97 
 
 
 
 139 
 
 
Subject T6A_03: baseline SBF: PF=13.22, PO= 13.39, PS= 9.54 
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 141 
Subject T6A_04: baseline SBF: PF=4.38, PO= 12.15, PS= 9.13 
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Subject T6A_05: baseline SBF: PF=8.75, PO= 3.54, PS= 5.69 
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 144 
Subject T6A_06: baseline SBF: PF=6.77, PO= 2.75, PS= 3.37 
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Subject T6A_07: baseline SBF: PF=3.45, PO= 3.82, PS= 3.00 
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 147 
Subject T6A_08: baseline SBF: PF=2.77, PO= 2.82, PS= 2.98 
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Subject T6A_09: baseline SBF: PF=7.68, PO= 8.15, PS= 10.00 
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 150 
Subject T6A_10: baseline SBF: PF=4.00, PO= 4.55, PS= 5.49 
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Subject T6A_11: baseline SBF: PF=4.87, PO= 3.44, PS= 3.57 
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Subject T6A_12: baseline SBF: PF=4.44, PO= 4.82, PS= 4.80 
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Subject T6A_13: baseline SBF: PF=6.26, PO= 3.75, PS= 3.26 
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 156 
Subject T6A_14: baseline SBF: PF=4.21, PO= 8.16, PS= 8.07 
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Subject T6A_15: baseline SBF: PF=5.42, PO= 9.96, PS= 10.30 
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Subject T6B_01: baseline SBF: PF=8.96, PO= 8.60, PS= 9.48 
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Subject T6B _02: baseline SBF: PF=3.57, PO= 2.87, PS= 4.33 
 
 161 
 
 
 
 
 162 
Subject T6B _03: baseline SBF: PF=4.35, PO= 4.55, PS= 4.60 
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Subject T6B _04: baseline SBF: PF=4.44, PO= 5.44, PS= 3.73 
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 165 
Subject T6B _05: baseline SBF: PF=2.27, PO= 2.61, PS= 7.07 
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Subject T6B _06: baseline SBF: PF=1.32, PO= 4.88, PS= 3.26 
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 168 
Subject T6B _07: baseline SBF: PF=3.05, PO= 3.32, PS= 6.39 
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Subject T6B _09: baseline SBF: PF=3.86, PO= 2.46, PS= 2.92 
 
 170 
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APPENDIX B 
HISTOGRAMS OF CURVE FIT PARAMETERS IN ALL THREE GROUPS 
All histograms here show the distribution of each curve-fit parameter by test sessions and by 
subject groups.  The purpose of this appendix is to show the different distribution among subject 
groups.  The parameters were from equation: 
€ 
y(t) = A1e− t /τ1 + A2e− t /τ2 + B. 
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B.1 A1/A2 
 
Control group: pressure with fast cooling 
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Control group: pressure only 
 
Control group: pressure with slow cooling 
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T6A group: pressure with fast cooling 
 
T6A group: pressure only 
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T6A group: pressure with slow cooling 
 
T6B group: pressure with fast cooling 
 
 176 
T6B group: pressure only 
 
T6B group: pressure with slow cooling 
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B.2 Τ1 
 
Control group: pressure with fast cooling 
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Control group: pressure only 
 
Control group: pressure with slow cooling 
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T6A group: pressure with fast cooling 
 
T6A group: pressure only 
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T6A group: pressure with slow cooling 
 
T6B group: pressure with fast cooling 
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T6B group: pressure only 
 
T6B group: pressure with slow cooling 
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B.3 Τ2 
 
Control group: pressure with fast cooling 
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Control group: pressure only 
 
Control group: pressure with slow cooling 
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T6A group: pressure with fast cooling 
 
T6A group: pressure only 
 
 185 
T6A group: pressure with slow cooling 
 
T6B group: pressure with fast cooling 
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T6B group: pressure only 
 
T6B group: pressure with slow cooling 
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